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CHAPTER 4 RESULTS 
 4.0 Introduction 
This section presents descriptive analyses of the demographic profile, levels of 
knowledge and fluid compliance status of acute and chronic haemodialysis patients. 
Measures of fluid compliance include interdialytic weight gain (IDWG), mean predialysis 
blood pressure (MPBP), rate of fluid adherence (RFA), source of information on fluid and 
salt control, the person giving advice, frequency of advice received, the form of teaching 
received, and correlational analyses between knowledge level and source of information, 
knowledge level, fluid compliance and patients’ demographic profile. This is followed by 
inferential statistics, which includes the comparison of differences in knowledge and fluid 
compliance between the control and experimental groups at both pre-and post-educational 
intervention. Multivariate analyses were used to identify factors associated with 
knowledge of fluid and salt control and fluid compliance. 
 
4.1 Study sample 
There were 291 participants recruited in Phase 1 of the study. Twenty-nine patients from 
Phase 1 dropped out, which reduced the sample size to 262 participants in Phase 2. 
Reasons for not taking part in Phase 2 were deaths (n = 24), transfers to other dialysis 
centres (n = 2), renal transplants (n = 2) and conversion to peritoneal dialysis (n = 1). A 
total of 9 patients from the experimental group and 20 from the control group dropped 
out. The total number of patients who participated in Phase 2 of the study was 145 from 
the experimental group and 117 from the control group. The details are summarized in 
Table 4.1. 
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Table 4.1: Number of patients recruited into the study 
 
 
 No. of chronic 
haemodialysis  
patients: 
 
No. Recruited  
Total chronic haemodialysis 
patients in 5 hospitals 
 
329 291 met inclusion criteria 
 
Phase 1 –survey 
 
291 291 
Phase 2 –educational    
               intervention  
 
291 262 (Response rate 90%) 
 
Experimental (N=154) 
Control (N=137) 
 
 
4.2 Patient characteristics 
The socio demographic characteristics for patients are shown in Table 4.2. The majority 
of the participants in both control and experimental groups were males and of Malay 
ethnicity. Participant age was normally distributed (Kolmogorov-Smirnov test, p = 0.2), 
ranging from 19 to 90 years, with mean±SD of 49.62±15.16. The distribution for the 
duration of dialysis therapy ranged from 6 to 360 months with a median of 60 months, 
with a positive skew (p < 0.001 in Kolmogorov-Smirnov test). Slightly over half of the 
patients (52.6%) had secondary education in both groups. Almost two-third of the patients 
(61%) were married. About one third (33.1%) of the patients were unemployed. 
Hypertension was a common concurrent disease (37.7%), with more than half of patients 
with hypertension (55.2%) on antihypertensive medications. There were no significant 
differences for most of the baseline characteristics between the experimental and control 
groups, as shown in Table 4.2. 
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Table 4.2: Characteristics of patients 
 
 
 Overall 
(N=291) 
 
Experimental 
(N=154)  
Control 
 (N=137) 
 Experimental 
vs. control  
2 
Mean age (SD), years 
 
52.14(15.05) 49.62(15.16) 54.97(14.45) 0.63 
Mean duration of 
dialysis therapy (SD), 
months 
86.2(65.44) 91.99(63.2) 79.69(67.5) 0.90 
Characteristics                                     n (%) 
 
 
Gender    
 
 
 
 
 
  
Male 178 (61.2) 
 
89 (57.8) 
 
89 (65)  
0.21 
 
 
Female 
 
113 (38.8) 
 
65 (42.2) 48 (35) 
 
Ethnicity  
 
 
 
 
    
       Malay   165 (56.7) 93 (60.4) 72 (52.6)  
       Chinese  97 (33.3) 44 (28.6) 53 (38.7) 0.13 
        India 26 (8.9) 14 (9.1) 12 (8.8)  
       Others  
 
3 (1.0) 3 (1.9) 0  
Educational level   
 
 
 
 
No education 19 (6.5) 
 
7 (4.5) 
 
12 (8.8) 
 
 
Primary 59 (20.3) 
 
26 (16.9) 
 
33 (24.1) 
 
0.06 
Secondary 151 (51.9) 81 (52.6) 
 
70 (51.1) 
 
 
Tertiary 
 
62 (21.3) 40 (26) 22 (16.1)  
Marital status  
 
    
Single 72 (24.7) 
 
42 (27.3) 30 (21.9)   
Married 183 (62.9) 
 
94 (61) 89 (65)  0.56 
Widow/widower 36 (12.4) 
 
18 (11.9) 18 (13.1)   
Employment  status      
Retired 94 (32.3) 50 (32.5) 44 (32.1)   
Unemployed 113 (38.8) 51 (33.1) 62 (45.3)  0.09 
Full time 72 (24.7) 45 (29.2) 27 (19.7)   
Part time 
 
12 (4.1) 8 (5.2) 4 (2.9)   
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‘Table 4.2, continued’ 
 
 
 
 
Overall 
(N=291) 
  
Experimental 
(N=154) 
Control 
 (N=137) 
 Experimental 
vs. control  
2 
Characteristics   n(%)   
Nil 
 
63 (21.6) 33(21.4) 30(21.9)  
Diabetes 
 
18 (6.2) 8(5.2) 10(7.3)  
Hypertension 
 
10(35.4) 58(37.7) 45(32.8)  
IHD 
 
1 (0.3) 0 1(0.7)  
Others 
 
15 (5.2) 10(6.5) 5(3.6) 0.38 
DM &HPT 
 
 
 
 
 
75 (25.8) 40(26) 35(25.5)  
HPT& IHD 
 
6 (2.1) 3(1.9) 3(2.2)  
DM,HPT&IHDǂ 
 
 
 
 
 
10 (3.4) 
 
 
 
1(1.3) 8(5.8)  
Antihypertensive 
therapy 
   
Yes  166  (57) 85(55.2) 81(59.1) 0.49 
No 125  (43) 69(44.8) 56(40.9) 
No. of 
antihypertensive 
medication   
    
0 126(43.3) 70(45.5) 56(40.9)  
1-2 132(45.4) 71(46.1) 61(44.5) 0.34 
3-4 33 (11.4) 13(8.4) 20(14.6) 
 
 
ǂ Note: 
DM-Diabetes mellitus  
HPT-Hypertension 
IHD-Ischemic heart disease  
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4.2.1 Pre-intervention fluid overload experience and symptoms    
Patients were asked if they had ever experienced fluid overload. Those who reported 
experiencing fluid overload were asked to describe its symptoms. In both experimental 
and control groups, more than half of the patients (65.6%) had experienced fluid 
overload. The most common symptoms experienced were difficulty in breathing (59.1%), 
followed by cramps during dialysis (9.5%). There were no statistically significant 
differences (p>0.05) between the proportion of patients that experienced fluid overload 
and fluid overload symptoms in the experimental and control group (Table 4.3). 
 
Table 4.3: Pre-intervention fluid overload experience and symptoms 
 
 
 
 
 
Overall (N=291) Experimental (N=154) Control (N=137) Experimental 
vs. control,2 
p-value 
 Yes 
n(%) 
No 
n(%) 
Yes 
n(%) 
No 
n(%) 
Yes 
n(%) 
No 
n(%) 
 
Fluid 
overload 
experience 
 
191(65.6) 100(34.4) 102(66.2) 52(33.8) 89(65) 48(35) 0.82 
 
 
 
Symptoms 
Overall (N=191) Experimental(N=102) Control (N=89) 
 
 
 
Yes 
n(%) 
No 
n(%) 
Yes                  
n(%) 
No 
n(%) 
Yes 
n(%) 
No 
n(%) 
 
        
Chest pain 18(6.2) 173(59.5) 14(9.1) 88(57.1) 4(2.9) 85(62) 0.09 
Difficulty 
in 
breathing  
 
 
172(59.1) 
 
19 (6.5) 
 
89(57.8) 
 
13(8.4) 
 
83(60.6) 
 
6(4.4) 
 
0.38 
Cramps 
during 
dialysis  
 
 
27(9.5 ) 
 
164(56.4) 
 
14(9.1) 
 
88(57.1) 
 
13(9.5) 
 
76(55.5) 
 
0.96 
Others 
(oedema) 
 
26(8.9) 165(56.7) 12(8.8) 77(56.2) 14(9.1) 88(57.1) 0.97 
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4.2.2 Sources of information about fluid and salt control 
Patients were asked if they had ever received any advice on fluid and salt control, the 
person who gave the advice, the frequency they received such advice and the form of 
information they received. From a total of 291 participants, 267 (91.8%) reported 
receiving information about fluid and salt control prior to this study. The participants 
indicated that the doctor (72.5%) was most often the person who advised them on fluid 
and salt control. Most of the participants (73.2%) reported that the advice was given in 
verbal form (Table 4.4). Comparison of the proportion of source of information between 
experimental and control groups revealed no statistically significant difference in advice 
received, frequency and form of information received (p>0.05). 
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Table 4.4: Pre-intervention source of information, frequency and 
form of information received 
 
 Overall 
(N=291) 
Experimental 
( N=154) 
Control 
(N=137) 
 
Experimental 
vs. control, 2  
P
 
 
 
Yes 
n(%) 
No 
n(%) 
Yes 
n(%) 
No 
n(%) 
Yes 
n(%) 
No 
n(%) 
 
Received 
any advice 
267(91.8) 24(8.2) 145(94.2) 9(5.8) 122(89.1) 15(10.9) 0.14 
 
 
 
Overall 
(N=267) 
Experimental 
( N=145) 
 
Control 
(N=122) 
Experimental 
vs. control, 2 
P
 
Source of 
information 
    
   Nurse 187 
(64.3) 
80 
(27.5) 
97 
(63) 
48 
(31.2) 
90 
(65.7) 
32 
(23.4) 
0.14 
   Doctor 211 
(72.5) 
56 
(19.2) 
119 
(77.3) 
26 
(16.9) 
92 
(67.2) 
30 
(21.9) 
0.12 
   Dietician 152 
(52.2) 
115 
(35.5) 
84 
(54.5) 
61 
(39.6) 
68 
(49.6) 
54 
(39.4) 
0.27 
   Others 22 
(7.60) 
245 
(84.2) 
9 
(5.8) 
136 
(88.3) 
13 
(9.5) 
109 
(79.6) 
0.12 
 
 
Overall  
n(%) 
Experimental  
n(%) 
Control  
n(%) 
 
Frequency 
advice 
received 
    
Every      
dialysis 
Session 
 
 
 
 
 
 
 
23(7.9) 13(8.4) 10(7.3)  
 
 
Monthly 12 (4.1) 7(4.5) 5(3.6)  
Weekly 8 (2.7) 6(3.9) 2(1.5) 0.6 
When 
problems 
occur 
226 (77.7) 118(76.6) 108(78.8)  
First time 
dialysis 
1(0.30) 0 1(0.6)  
 
Form of 
teaching 
received 
    
Verbal 213  (73.2) 121(78.6) 92(67.2)  
Written/ 
leaflet 
7 (2.4) 5(3.2) 2(1.5) 0.05 
Verbal & 
leaflet 
48 (16.5) 18(11.7) 30(21.9)  
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4.3 Pre-intervention knowledge on fluid and salt control 
 
4.3.1 Analysis of questionnaire  
The knowledge assessment was conducted at baseline and 3 months after the educational 
intervention was implemented. Knowledge on fluid and salt control was assessed using a 
questionnaire (Appendix A).  The correct response to each question is displayed in Table 
4.5. 
 
Pre- intervention 
Generally, there was no statistical significant difference in the proportion of correct 
responses between the experimental and control group. On the whole, for question 1 and 
6, the majority responded correctly (90%). The participants in the experimental group had 
the highest proportion of correct responses for Question 1 (97.4%), followed by Question 
6 (96.1%). However, only 42.2% of the participants in the experimental group responded 
correctly on Question 3, and 51.9% on Question 8. 
 
In the control group, the highest correct responses was for Question 1 (95.6%) and 
Question 6 (95.6%).The proportion of correct responses in the control group was low 
(37.2%) for Question 8 (Table 4.5). 
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Post- intervention  
There were no statistically significant differences in the proportion of correct responses 
assessed at baseline and after 3 months. The educational intervention was initiated for 3 
months in the experimental group with notable improvements after the intervention. The 
control group did not receive any educational intervention. All participants in the 
experimental group answered Question 1 correctly. However, the odds ratio was low (OR 
0.97, 95%CI 0.94 to 1.00). This is indicated by the higher proportion of correct responses 
in the control group compared to the experimental group.  In the experimental group, the 
proportion of correct answers increased after the intervention, particularly for Question 3 
(42.2% to 71.4%), Question 4 (62.3% to 83.8%), Question 7 (61.1% to 72.15%) and 
Question 8 (51.9% to 96.8%). On the whole, the experimental group had a higher 
proportion of correct responses for most of the questions than the control group, as 
indicated by the odds ratios (ORs) and their respective 95% CI, as showed in Table 4.5. 
The 95% CI did not include Question 1, as statistically significant improvements in 
correct responses was only observed in Question 3 (OR 1.78, 95%CI 1.09 to 2.90), 
Question 4 (OR 4.27, 95%CI 2.47 to 7.35), Question 5 (OR 1.84, 95%CI 1.10 to 3.10) 
and Question 8 (OR 28.52, 95%CI 11.00 to 73.90) after the intervention. The OR 
(95%CI) for correct responses on Question 4 was 4.27 (2.47 to 7.35) which indicated that 
the experimental group had a 4.27 times higher likelihood of correct responses than the 
control group after the intervention. For Question 6, the OR of 2.29 (95%CI 0.41 to 
12.68) implies the experimental group had almost 3 times higher likelihood of correct 
responses than the control group after the intervention, but the association was not 
significant as the range of the 95%CI includes 1. 
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Table 4.5: Correct responses for individual knowledge questions,  
pre- and post- intervention 
 
  
 
 
 
 
Pre intervention Post Intervention Correct 
response 
experimental vs. 
control group 
Questions 
 
Experimental 
(N=154) 
n (%) 
Control 
(N=137) 
n(%) 
Experimental 
(N=154) 
n (%) 
Control 
(N=137) 
n(%) 
Odds ratio(OR) 
(95%CI) 
 
Q1 Purpose of 
haemodialysis 
treatment 
 
150  
(97.4) 
131  
( 95.6) 
154 
(100) 
133 
(97.1) 
0.97 
(0.94-1.00) 
Q2 Importance of 
fluid and salt    
restriction 
 
99    
(64.3) 
98 
(71.5) 
 
125 
(81.2) 
99 
(72.3) 
1.65 
(0.95-2.87) 
Q3 Amount of 
water you need 
to drink per day 
is 1 liter (1000 
mls) 
 
65  
(42.2) 
75     
(54.7) 
110 
(71.4) 
80 
(58.4) 
1.78 
(1.09-2.90) 
Q4 Salt intake per 
day should be 
limit to 2-4 
gram (½ to 1  
 
 
teaspoon). 
 
96   
(62.3) 
70    
 (51.1) 
129 
(83.8) 
75 
(54.7) 
4.27 
(2.47-7.35) 
Q5 Allowed to put 
on weight 1.5-2 
kg between 
dialysis    
intervals 
 
93   
(60.4) 
91     
(66.4) 
120 
(77.9) 
90 
(65.7) 
1.84 
(1.10-3.10) 
 
 
 
 Q6 Aware the 
danger of 
drinking   too 
much of water 
 
148  
(96.1) 
133   
(97.1) 
152 
(98.7) 
133 
(97.1) 
2.29 
(0.41-12.68) 
Q7 Food like ice 
cream, jelly is 
safe to eat 
because it 
contains less 
water. 
 
94   
(61.1) 
95 
(69.3) 
111   
(72.1) 
 
93 
(67.9) 
1.22 
(0.74- 2.02) 
 
Q8 Drinking from 
small cups and 
eat ice cube can 
help in control 
fluid intake. 
 
80 
(51.9) 
51 
(37.2) 
149 
 (96.8) 
70 
(51.1) 
28.52 
(11.00-73.90) 
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4.4 Assessment of the level of knowledge and its association with source of 
information pre- and post-intervention  
 
4.4.1  Knowledge levels pre- and post-intervention in the experimental and control  
group 
Table 4.6 shows the knowledge levels (pre- and post-intervention) for both the control 
and experimental groups. The knowledge scores of the participants were further classified 
into the categories of “high knowledge levels” and “poor knowledge levels”. Patients 
with mean total knowledge scores of 4 and below were grouped as having “low 
knowledge levels” and those with mean total knowledge score of 5 and above were 
grouped as “high knowledge levels”. Both experimental and control groups had lower 
proportions of participants in the “high knowledge level” group in the pre-intervention 
phase, with no significant differences (p>0.05) between the two groups. In the post-
intervention phase, the experimental group had a higher proportion of participants in the 
“high knowledge level” category compared to the control group. This difference was 
statistically significant (p<0.05). 
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Table 4.6: Knowledge levels pre -and post intervention in the control  
and experimental group 
 
 
 Pre- intervention Between 
Exp. vs. 
Control 
χ2 
 
Post - intervention Between 
Exp. vs. 
Control 
χ2 
 
Mean total 
knowledge 
score† 
 
Overall  
M(SD) 
0-4 
 
n(%) 
5-8 
 
n(%) 
p Overall 
M(SD)  
0-4 
 
n(%) 
5-8 
 
n(%) 
p  
Experimental 
 (n=154) 
 
5.80 
(1.31) 
60  
(39) 
94  
(61) 
 
0.12 
6.48 
(0.86) 
26  
(16.9) 
128 
(83.1) 
 
0.00 
Control  
(n=137) 
 
5.56 
(1.14) 
64  
(46.7) 
73  
(53.3) 
5.70 
(1.08) 
54  
(39.4) 
83 
(60.6) 
†Note: 
Mean total knowledge score 0-4 imply low knowledge level 
Mean total knowledge score 5-8 imply high knowledge level 
 
 
4.4.2 Association between knowledge level and ever received information  
When patients were asked whether they had previously received any information on fluid 
and salt control, the majority of the patients responded “yes” in both the experimental and 
control groups but the proportion who responded “yes” for the group with “high 
knowledge levels” was relatively low (62.8% and 54.1%, respectively) in the pre-
intervention phase (Table 4.7). In the experimental group, the proportion which 
responded “yes” in the “high knowledge levels” group at post- intervention increased 
from 62.8% to 82.8%. Comparison using chi square within experimental and control 
groups at the pre- and post- intervention phase showed no statistically significant 
difference (p>0.05). However, there was a significant difference in the knowledge level 
between the experimental and control groups at the post- intervention phase (p<0.05) as 
shown in Table 4.7 
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Table 4.7: Association between knowledge levels and  
ever received information 
 
 
 Pre- 
intervention 
Within 
Exp. 
χ2 
 
Between 
Exp. vs 
control 
χ2 
 
 Post- 
intervention 
Within 
Control 
χ2 
 
Between 
Exp. vs 
control 
χ2 
Mean total 
knowledge 
score† 
 
0-4 
 n(%) 
 
5-8 
n(%) 
 
p p  0-4 
n(%) 
 
5-8 
n(%) 
 
p p 
 
 
 
 
 
 
 
Experimental 
(n=154) 
     
 
 
 
0.15 
    
Received  
information 
previously  
         
Yes 54 
(37.2) 
 
91 
(62.8) 
 
 
0.08 
  25 
(17.2) 
 
120 
(82.8) 
 
 
0.63 
 
 
 
No 6 
(66.7) 
 
3 
(33.3) 
 
 
 
0.15 
 1 
(11.1) 
8 
(88.9) 
 
 
 
0.00 Control  
(n=137) 
       
Received  
information 
previously  
         
Yes 56 
(45.9) 
66 
(54.1) 
 
 
0.59 
  48 
(39.3) 
74 
(60.7) 
 
 
0.96 
 
No  8 
(53.3) 
7 
(46.7) 
  6 
(40.0) 
9 
(60.0) 
 
†Note: 
A mean total knowledge score of 0-4 implies low knowledge levels 
A mean total knowledge score of 5-8 implies high knowledge levels 
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4.5 Comparison of the mean total knowledge on fluid and salt control by 
demographic and clinical characteristics pre- and post- intervention between 
experimental and control groups 
 
4.5.1  Comparison of mean total knowledge score by demographic and clinical  
          characteristics 
 
A repeated-measure ANOVA was used to determine mean total knowledge differences 
between and within the experimental and control groups, pre-and post-intervention. Table 
4.8 displays mean total knowledge by demographic and clinical characteristics for both 
experimental and control groups. There was no difference in mean total knowledge within 
the experimental and control group (p<0.05) pre- and post-intervention. However, a 
significant difference (p<0.05) was observed between experimental and control groups.  
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Table 4.8: Mean total knowledge by demographic and clinical characteristics  
pre- and post-intervention in both experimental and control groups 
 
 
 
 
 
 
 
 
 
Experimental 
 (N=154) 
 
 
Within  
Group 
 
(Exp vs. 
Exp) 
 
Control  
(N=137) 
 
Within 
Group 
 
(Control  
vs. 
Control) 
Between 
group 
 
(Exp vs. 
control ) 
  
 Mean total knowledge 
Mean (SD) 
p Mean total knowledge 
Mean (SD) 
p p 
 
Characteristics n 
(%) 
Pre- 
interven-
tion 
Post- 
interven-
tion 
 n 
(%) 
Pre- 
interven- 
tion 
Post- 
interve
n-tion 
  
Age group  
(years) 
 
         
<40     42 
(27.3) 
5.69 
(1.40) 
6.52 
(0.77) 
 
 20 
(14.6) 
5.60 
(0.88) 
5.85 
(0.93) 
  
40-50 25 
(16.2) 
6.32 
(1.11) 
6.76 
(0.83) 
0.38 28 
(20.4) 
5.25 
(0.96) 
5.39 
(0.92) 
0.77 <0.001 
50-60 43 
(27.9) 
5.98 
(1.18) 
6.53 
(0.90) 
 31 
(22.6) 
5.77 
(1.28) 
5.87 
(1.28) 
  
>60  44 
(28.6) 
5.45 
(1.35) 
6.23 
(0.86) 
 58 
(42.3) 
5.58 
(1.21) 
5.70 
(1.07) 
  
Gender            
Male 88 
(57.1) 
5.72 
(1.38) 
6.41 
(0.89) 
0.89 89 
(65.0) 
5.45 
(0.97) 
5.63 
(0.96) 
0.22 <0.001 
Female 66 
(42.9) 
5.92 
(1.20) 
6.58 
(0.80) 
 48 
(35.0) 
5.77 
(1.39) 
5.83 
(1.28) 
  
Ethnicity           
Malay  93 
(60.4) 
5.98 
(1.33) 
6.62 
(0.85) 
 72 
(52.6) 
5.49 
(1.21) 
5.71 
(1.09) 
  
Chinese  44 
(28.6) 
5.40 
(1.17) 
6.12 
(0.82) 
0.92 53 
(38.7) 
5.47 
(0.97) 
5.53 
(0.95) 
0.15 <0.001 
Indian  14 
(9.1) 
6.07 
(1.44) 
6.71 
(0.73) 
 12 
(8.8) 
6.42 
(1.16) 
6.42 
(1.13) 
  
Others 
 
 
 
 
  
3 
(1.9) 
5.00 
(1) 
6.00 
(1) 
 0 - -   
Note:  
Within group – pre and post comparison within experimental and control  
Between group –comparison between experimental and control  
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‘Table 4.8, continued’ 
 
 
 
 
 
 
 
Experimental 
 (N=154) 
 
 
Within  
Group 
 
(Exp vs. 
Exp) 
 
Control  
(N=137) 
 
Within 
Group 
 
(Control  
vs. 
Control) 
Between 
group 
 
(Exp vs. 
control ) 
  
 Mean total knowledge 
Mean (SD) 
p Mean total knowledge 
Mean (SD) 
p p 
 
Characteristics n 
(%) 
Pre- 
interven-
tion 
Post- 
interven-
tion 
 n 
(%) 
Pre- 
interven- 
tion 
Post- 
interven-
tion 
  
Educational 
 level 
         
No 
education 
8 
(5.2) 
5.50 
(0.93) 
6.38 
(0.74) 
 12 
(8.80) 
5.33 
(1.56) 
5.42 
(1.38) 
  
Primary 
 
 
26 
(16.9) 
5.65 
(1.23) 
6.3 
(10.88) 
0.86 33 
(24.0) 
5.70 
(1.21) 
5.85 
(1.15) 
0.78 <0.001 
Secondary 80 
(51.9) 
5.85 
(1.36) 
6.50 
(0.90) 
 70 
(51.1) 
5.61 
(11.13) 
5.79 
(1.05) 
  
Tertiary 
 
40 
(26) 
5.87 
(1.34) 
6.58 
(0.78) 
 22 
(16.1) 
5.32 
(0.78) 
5.36 
(0.85) 
  
Marital status 
         
Single 42 
(27.3) 
5.57 
(1.32) 
6.45 
(0.83) 
 30 
(21.9) 
5.46 
(1.19) 
5.67 
(1/02) 
  
Married 94 
(61.0) 
5.84 
(1.35) 
6.52 
(0.89) 
0.05 89 
(65.0) 
5.69 
(1.11) 
5.81 
(1.08) 
0.72 <0.001 
Widow/ 
widower 
18 
(11.7) 
6.17 
(0.92) 
6.33 
(0.84) 
 18 
(13.1) 
5.05 
(1.26) 
5.22 
(1.06) 
  
Employment  
status 
         
Retired 50 
(32.5) 
5.36 
(1.32) 
6.36 
(0.90) 
 44 
(32.1) 
5.55 
(1.02) 
5.61 
(1.04) 
  
Unemployed 51 
(33.1) 
5.80 
(1.22) 
6.47 
(0.80) 
0.93 62 
(45.3) 
5.69 
(1.31) 
5.81 
(1.21) 
0.33 <0.001 
Full time 45 
(29.2) 
6.02 
(1.23) 
6.67 
(0.80) 
 27 
(19.7) 
5.37 
(0.84) 
5.67 
(0.83) 
  
Part time 
 
8 
(5.2) 
5.75 
(1.58) 
6.25 
(1.17) 
 4 
(2.9) 
5.00 
(1.41) 
5.25 
(0.96) 
  
Duration of 
dialysis 
 
trherapytherap
y 
         
<5 years  54 
(35.1) 
5.81 
(1.45) 
6.65 
(0.78) 
 64 
(46.8) 
5.61 
(1.01) 
5.78 
(1.00) 
  
5-10years 46 
(29.9) 
5.80 
(1.22) 
6.28 
(0.91) 
0.40 41 
(29.9) 
5.68 
(1.29) 
5.78 
(1.24) 
0.88 <0.01 
10-15years 39 
(25.3) 
5.67 
(1.28) 
6.38 
(0.88) 
 18 
(13.1) 
5.28 
(1.36) 
5.50 
(1.10) 
  
>15years 15 
(9.7) 
6.13 
(1.22) 
6.73 
(0.80) 
 14 
(10.2) 
5.21 
(0.89) 
5.36 
(0.93) 
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‘Table 4.8, continued’ 
 
 
 
 
 
 
 
 
Experimental 
 (N=154) 
 
 
Within  
Group 
 
(Exp vs. 
Exp) 
 
Control  
(N=137) 
 
Within 
Group 
 
(Control  
vs. 
Control) 
Between 
group 
 
(Exp vs. 
control ) 
  
 Mean total knowledge 
Mean (SD) 
p Mean total knowledge 
Mean (SD) 
p p 
 
Characteristics n 
(%) 
Pre- 
interven-
tion 
Post- 
interven-
tion 
 n 
(%) 
Pre- 
interven- 
tion 
Post- 
interven
-tion 
  
No. of 
concurrent 
disease 
 
 
d 
 disease 
         
Nil 
 
33 
(21.4) 
5.76 
(1.20) 
6.42 
(0.82) 
 30 
(21.9) 
5.47 
(1.01) 
5.57 
(0.90) 
  
<2 types  76 
(49.4) 
5.68 
(1.36) 
6.46 
(0.89) 
0.41 61 
(44.5) 
5.28 
(1.16) 
5.48 
(1.07) 
0.52 <0.001 
>2 types  45 
(29.2) 
6.03 
(1.30) 
6.56 
(0.84) 
 46 
(33.6) 
6.00 
(1.10) 
6.09 
(1.11) 
  
Anti- 
hypertensive 
therapy 
 
 
 
drugs  
         
Yes  85 
(55.2) 
5.84 
(1.18) 
6.49 
(0.84) 
0.71 81 
(59.1) 
5.70 
(1.18) 
5.81 
(1.16) 
 
0.47 
 
<0.001 
No 69 
(44.8) 
5.75 
(1.24) 
6.46 
(0.88) 
 56 
(40.9) 
5.35 
(1.06) 
5.54 
(0.93) 
 
No. of anti- 
hypertensive  
medication 
         
Nil  70 
(45.5) 
5.71 
(1.28) 
6.46 
(0.88) 
 57 
(41.6) 
5.36 
(1.07) 
5.54 
(0.93) 
  
1 type 36 
(23.4) 
5.69 
(1.39) 
6.50 
(0.85) 
0.29 37 
(27.0) 
5.32 
(1.08) 
5.46 
(1.07) 
 
0.76 
 
<0.001 
More than 1 
type 
48 
(31.1) 
6.02 
(1.30) 
6.50 
(0.85) 
 43 
(31.4) 
 
 
 
6.02 
(1.21) 
6.12 
(1.20) 
 
Note:  
Within group – pre and post comparison within experimental and control  
Between group –comparison between experimental and control  
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4.5.1.2 Comparison of mean total knowledge score by demographic and clinical     
            characteristics (post hoc analysis) 
 
The mean total knowledge scores by demographic and clinical characteristics at the pre- 
and post- intervention phase for both experimental and control groups are displayed in 
Table 4.9. The maximum total knowledge score was 8 points. In the pre-intervention 
phase, the 40-50 age group reported the highest mean knowledge score (6.32±1.11), 
whereas the lowest mean knowledge score was reported among retired participants 
(5.36±1.32)  Comparison of mean knowledge score by gender showed that the highest 
mean knowledge score were among females in the control group (5.77±1.39). The Indian 
ethnic group obtained the highest mean total knowledge score in pre- and post- 
intervention (6.07±1.44 and 6.71±0.73 respectively). By occupational categories, patients 
with part time employment had the lowest mean knowledge scores (5.00±1.41). There 
was an increase in post-intervention knowledge scores with the experimental group 
obtaining higher scores than the control group. The highest post-intervention knowledge 
score for the experimental group was 6.76±0.83 (from the 40-50 age subgroup) while the 
highest score in control group was 6.12±1.20 (from the subgroup of patients on more than 
one type of antihypertensive medication). 
 
Tests of normality for knowledge scores before and after the educational intervention 
were conducted using normality plots. Result showed both scores were normality 
distributed (Kolmogorov-Smirnov test, p=0.00). Parametric statistic was applied using 
paired t-tests to determine knowledge differences pre- and post- intervention for both the 
control and experimental group. In the experimental group, there were significant 
increases in mean knowledge scores post-intervention for almost all demographic and 
clinical characteristics except for Indians and other ethnic minorities, widowers and part-
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time employment subgroups) (p<0.05). In the control group, significant differences in 
mean knowledge scores at both pre -and post- intervention was found in the following 
subgroups: male, secondary education, unmarried, full time employment, patients not on 
any antihypertensive medication and with less than 2 types of concurrent disease 
(p<0.05). 
 
An independent t-test was conducted to determine significant differences between the 
experimental and control groups on total knowledge scores on fluid and salt control at 
pre- and post-intervention. Comparison between the experimental and control groups at 
post-intervention using an independent t-test showed statistically significant differences 
in mean knowledge score by demographic and clinical characteristics. However, there 
were no statistically significant differences in the mean knowledge score for patients of 
Indian ethnic origin, primary education and of part time employment post-intervention for 
the experimental group (Table 4.9). 
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Table 4.9: Post hoc analysis of mean total knowledge by demographic and clinical 
characteristics pre- and post-intervention in both experimental and control groups 
 
 
 
 
 
 
 
 
Experimental 
(N=154) 
 
 
Within 
group 
(Exp vs. 
exp) 
 
 
Control 
(N=137) 
 
Within 
group 
(control 
vs. 
control) 
Between 
group 
(Exp vs. 
control ) 
 
  Mean total knowledge 
Mean (SD) 
Paired t 
test, 
p 
Mean total knowledge 
Mean (SD) 
Paired 
t test,  
p 
Indepe
d-ent  
t test,  
p 
 
Characteris-
tics 
n 
(%) 
Pre- 
intervent-
ion 
Post- 
intervent
-ion 
 n  
(%) 
Pre- 
Intervent
-ion 
Post- 
intervent
-ion 
  
Age group  
(years) 
 
         
<40     42 
(27.3
) 
5.69 
(1.40) 
6.52 
(0.77) 
 
<0.001 20 
(14.6) 
5.60 
(0.88) 
5.85 
(0.93) 
0.06 0.04 
40-50 25 
(16.2
) 
6.32 
(1.11) 
6.76 
(0.83) 
0.02 28 
(20.4) 
5.25 
(0.96) 
5.39 
(0.92) 
0.21 <0.001 
50-60 43 
(27.9
) 
5.98 
(1.18) 
6.53 
(0.90) 
<0.001 31 
(22.6) 
5.77 
(1.28) 
5.87 
(1.28) 
0.26 0.01 
>60  44 
(28.6
) 
5.45 
(1.35) 
6.23 
(0.86) 
<0.001 58 
(42.3) 
5.58 
(1.21) 
5.70 
(1.07) 
0.09 0.01 
Gender            
Male 88 
(57.1) 
5.72 
(1.38) 
6.41 
(0.89) 
<0.001 89 
(65.0) 
5.45 
(0.97) 
5.63 
(0.96) 
0.00 <0.001 
Female  66 
(42.9) 
5.92 
(1.20) 
6.58 
(0.80) 
<0.001 48 
(35.0) 
5.77 
(1.39) 
5.83 
(1.28) 
0.37 0.01 
Ethnicity           
Malay  93 
(60.4) 
5.98 
(1.33) 
6.62 
(0.85) 
<0.001 72 
(52.6) 
5.49 
(1.21) 
5.71 
(1.09) 
0.00 0.02 
Chinese  44 
(28.6) 
5.40 
(1.17) 
6.12 
(0.82) 
<0.001 53 
(38.7) 
5.47 
(0.97) 
5.53 
(0.95) 
0.47 0.001 
Indian  14 
(9.1) 
6.07 
(1.44) 
6.71 
(0.73) 
0.05 12 
(8.8) 
6.42 
(1.16) 
6.42 
(1.13) 
0.99 0.47 
Others  3 
(1.9) 
5.00 
(1) 
6.00 
(1) 
0.23 0 - - - - 
Educational 
level 
         
No 
education 
8 
(5.2) 
5.50 
(0.93) 
6.38 
(0.74) 
0.02 12 
(8.80) 
5.33 
(1.56) 
5.42 
(1.38) 
0.67 0.09 
Primary 
 
 
26 
(16.9) 
5.65 
(1.23) 
6.3 
(10.88) 
0.04 33 
(24.0) 
5.70 
(1.21) 
5.85 
(1.15) 
0.17 0.10 
Secondary 80 
(51.9) 
5.85 
(1.36) 
6.50 
(0.90) 
<0.001 70 
(51.1) 
5.61 
(11.13
) 
5.79 
(1.05) 
0.01 <0.001 
Tertiary 
 
40 
(26) 
5.87 
(1.34) 
6.58 
(0.78) 
<0.001 22 
(16.1) 
5.32 
(0.78) 
5.36 
(0.85) 
0.58 <0.001 
Note:  
Within group – pre and post comparison within experimental and control  
Between group –comparison between experimental and control  
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‘Table 4.9, continued’ 
 
 
 
 
 
 
 
 
Experimental 
(N=154) 
 
 
Within 
group 
(Exp vs. 
exp) 
 
 
Control 
(N=137) 
 
Within 
group 
(control 
vs. 
control) 
Between 
group 
(Exp vs. 
control ) 
 
  Mean total knowledge 
Mean (SD) 
Paired t 
test, 
p 
Mean total knowledge 
Mean (SD) 
Paired 
t test,  
p 
Indepe
d-ent  
t test,  
p 
 
Characteris-
tics 
n  
(%) 
Pre- 
intervent-
ion 
Post- 
intervent
-ion 
 n  
(%) 
Pre- 
Intervent
-ion 
Post- 
intervent
-ion 
  
Marital 
status 
         
Single 42 
(27.3) 
5.57 
(1.32) 
6.45 
(0.83) 
<0.001 30 
(21.9) 
5.46 
(1.19) 
5.67 
(1/02) 
0.03 <0.001 
Married 94 
(61.0) 
5.84 
(1.35) 
6.52 
(0.89) 
<0.001 89 
(65.0) 
5.69 
(1.11) 
5.81 
(1.08) 
0.05 <0.001 
Widow/ 
widower 
18 
(11.7) 
6.17 
(0.92) 
6.33 
(0.84) 
0.42 18 
(13.1) 
5.05 
(1.26) 
5.22 
(1.06) 
0.27 0.01 
Employment  
status 
         
Retired 50 
(32.5) 
5.36 
(1.32) 
6.36 
(0.90) 
<0.001 44 
(32.1) 
5.55 
(1.02) 
5.61 
(1.04) 
0.32 <0.001 
Unemployed 51 
(33.1) 
5.80 
(1.22) 
6.47 
(0.80) 
<0.001 62 
(45.3) 
5.69 
(1.31) 
5.81 
(1.21) 
0.13 0.01 
Full time 45 
(29.2) 
6.02 
(1.23) 
6.67 
(0.80) 
<0.001 27 
(19.7) 
5.37 
(0.84) 
5.67 
(0.83) 
0.01 <0.001 
Part time 
 
8 
(5.2) 
5.75 
(1.58) 
6.25 
(1.17) 
0.23 4 
(2.9) 
5.00 
(1.41) 
5.25 
(0.96) 
0.39 0.17 
Duration 
of dialysis 
therapy 
         
<5 years  54 
(35.1) 
5.81 
(1.45) 
6.65 
(0.78) 
<0.001 64 
(46.8) 
5.61 
(1.01) 
5.78 
(1.00) 
0.05 <0.001 
5-10years 46 
(29.9) 
5.80 
(1.22) 
6.28 
(0.91) 
0.003 41 
(29.9) 
5.68 
(1.29) 
5.78 
(1.24) 
0.25 0.03 
10-15years 39 
(25.3) 
5.67 
(1.28) 
6.38 
(0.88) 
<0.001 18 
(13.1) 
5.28 
(1.36) 
5.50 
(1.10) 
0.10 <0.001 
>15years 15 
(9.7) 
6.13 
(1.22) 
6.73 
(0.80) 
0.03 14 
(10.2) 
5.21 
(0.89) 
5.36 
(0.93) 
0.17 0.01 
 
No. of 
concurrent  
disease 
         
Nil 
 
33 
(21.4) 
5.76 
(1.20) 
6.42 
(0.82) 
0.01 30 
(21.9) 
5.47 
(1.01) 
5.57 
(0.90) 
0.26 <0.001 
<2 types  76 
(49.4) 
5.68 
(1.36) 
6.46 
(0.89) 
<0.001 61 
(44.5) 
5.28 
(1.16) 
5.48 
(1.07) 
0.02 <0.001 
>2 types  45 
(29.2) 
6.03 
(1.30) 
6.56 
(0.84) 
<0.001 46 
(33.6) 
6.00 
(1.10) 
6.09 
(1.11) 
0.16 0.03 
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 “Table 4.9, continued” 
 
 
 
 
 
 
 
 
Experimental 
(N=154) 
 
 
Within 
group 
(Exp vs. 
exp) 
 
 
Control 
(N=137) 
 
Within 
group 
(control 
vs. 
control) 
Between 
group 
(Exp vs. 
control ) 
 
 
 Mean total knowledge 
Mean (SD) 
Paired t 
test, 
p 
Mean total knowledge 
Mean (SD) 
Paired 
t test,  
p 
Indepe
d-ent  
t test,  
p 
 
Characteris
-tics 
n (%) Pre- 
intervent
-ion 
Post- 
intervent
-ion 
 n  
(%) 
Pre- 
Intervent
-ion 
Post- 
intervent
-ion 
  
Anti- 
hypertensive 
therapy 
 
 
 
drugs  
         
Yes  85 
(55.2) 
5.84 
(1.18) 
6.49 
(0.84) 
<0.001 81 
(59.1) 
5.70 
(1.18) 
5.81 
(1.16) 
0.06 <0.001 
No 69 
(44.8) 
5.75 
(1.24) 
6.46 
(0.88) 
<0.001 56 
(40.9) 
5.35 
(1.06) 
5.54 
(0.93) 
0.02 <0.001 
No. of 
antihypertensive  
medication 
         
Nil  70 
(45.5) 
5.71 
(1.28) 
6.46 
(0.88) 
<0.001 57 
(41.6) 
5.36 
(1.07) 
5.54 
(0.93) 
0.02 <0.001 
1 type 36 
(23.4) 
5.69 
(1.39) 
6.50 
(0.85) 
<0.001 37 
(27.0) 
5.32 
(1.08) 
5.46 
(1.07) 
0.13 <0.001 
More 
than 1 
type 
48 
(31.1) 
6.02 
(1.30) 
6.50 
(0.85) 
<0.001 43 
(31.4) 
 
 
 
6.02 
(1.21) 
6.12 
(1.20) 
0.25 0.09 
Note:  
Within group – pre and post comparison within experimental and control  
Between group –comparison between experimental and control  
 
 
 
 
 
 
 
98 
 
4.5.2 Comparison of pre -and post-intervention mean total knowledge scores for  
         the experimental and control group   
 
Table 4.10 showed pre- and post-intervention comparisons on mean total knowledge 
scores for both the experimental and control group. The overall mean total knowledge 
scores for the experimental group were higher than the control group pre- and post- 
intervention. A paired t- test was used to compare the mean total knowledge scores pre- 
and post-intervention within the experimental and control group. Both groups showed 
significant differences in mean knowledge scores pre- and post-intervention. 
  
In the pre-intervention phase, no significant differences were observed in the mean 
knowledge score for the experimental (5.80 ±1.30) and control (5.56±1.14) group. There 
was a statistically non-significant increase of 0.14 (95% CI 0.05 to 0.23) in the control 
group. At the post- intervention phase, the mean knowledge increment for the treatment 
group was found to be statistically significant (0.68, 95% CI 0.50 to 0.84). 
 
An independent t-test was conducted to compare mean total knowledge scores between 
the experimental and control groups pre- and post-intervention. In the pre-intervention 
phase, the mean total knowledge score for the experimental group (5.80±1.31) and control 
group (5.56±1.14) showed no significance difference (0.24, 95% CI 0.05 to 0.53) between 
both groups. However, there was an increase in mean total knowledge scores post- 
intervention. The mean total knowledge scores for the experimental group (6.48±0.86) 
was higher than the control group (5.70±1.08).There was a significant difference in mean 
knowledge scores between the experimental and the control group post-intervention 
(0.78, 95% CI 0.56 to 1.01). 
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Table 4.10: Comparisons on mean total knowledge on fluid and salt control between the 
experimental and control groups pre- and post-intervention 
 
 
 Pre- 
intervention 
Between group 
Exp vs. control  
 Post- 
intervention 
Between 
group 
Exp vs. 
control  
 Within   
Group 
 Mean total 
knowledge 
score  
 
 
 
 
 
score 
 
Diff 
(95% 
CI) 
Indept. 
 t test  
p 
Mean total 
knowledge 
score 
 
 
Diff 
(95% 
CI) 
Indept 
test  
p 
 Diff 
(95% 
CI) 
 
 
Paired 
 t test 
p 
Experimental 
 (n=154) 
5.80 
(1.31) 
 
 
0.24 
(-0.04, 
0.53) 
 
 
 
0.09 
 
6.48 
(0.86) 
 
 
 
0.78 
(0.56, 
1.01) 
 
 
 
0.00 
 0.68 
(0.50, 
0.84) 
0.00 
Control  
(n=137) 
 
 
5.56 
(1.14) 
5.70 
(1.08) 
 0.14 
(0.05, 
0.23) 
0.02 
 
Note:  
Within group – pre and post comparison within experimental and control  
Between group –comparison between experimental and control  
 
 
 
4.6 Evaluating the effectiveness of patient education on knowledge improvement for 
both experimental and control groups  
 
4.6.1 Evaluating the effectiveness of the educational intervention on the level of 
knowledge on fluid and salt control for both experimental and control groups 
 
Knowledge on fluid and salt control was assessed once pre-intervention and 3 months 
post-intervention. The knowledge scores were divided into two categories - “good 
knowledge level” (scores ranging from 5-8) and “poor knowledge level” (scores ranging 
from 0-4). Knowledge improvement in this context is defined as recorded knowledge 
changes from “poor knowledge levels” at the pre-intervention phase to “good knowledge 
levels” at post-intervention. Table 4.11 showed the outcomes for knowledge improvement 
post- intervention. 
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The experimental group  
There were one hundred twenty eight (n = 128) participants with good knowledge levels 
pos-intervention. Forty-five participants showed improvements post-intervention while 83 
participants maintained high knowledge levels. 
The control group  
There were eighty-three participants with good knowledge levels post-intervention. Of 
these 13 participants demonstrated improvement from low to high knowledge levels 
while an additional 70 participants maintained high knowledge levels. 
 
Both experimental and control groups showed knowledge improvement on fluid and salt 
control post-intervention. The proportion of participants which showed knowledge 
improvement was higher in the experimental group (29.2%) than in the control group 
(9.5%). The odds ratio (OR 3.94, 95%CI 2.02 to 7.69) showed that 3-month post- 
intervention, the experimental group had a higher odds with almost 4 times the 
knowledge improvement than the control group (Table 4.11). 
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Table 4.11: Outcome for knowledge improvement on fluid and salt control post- 
intervention for both experimental and control groups 
 
 Experimental 
(n=154) 
 Experimental 
group 
knowledge  
improved in 
3- month 
post-  
intervention 
 Control (n=137)  Control  
group 
knowledge 
improved in 
3- month 
post-  
intervention 
 Odds ratio 
(95%CI) of 
improved 
knowledge  
for 
experimental 
versus 
control 
 Pre 
 
Post n (%) Pre Post n(%) OR 
(95%) 
Knowledge 
scores † 
 
   
45(29.2) 
 
 
 
   
13(9.5) 
 
 
 
 
3.94 
(2.02-7.69) 
 0-4 60 
(39%) 
 
26 
(16.9%) 
64 
(46.7%) 
54 
(39.4%) 
5-8 94 
(61%) 
128 
(83.1%) 
 
73 
(53.3%) 
83  
(60.6%) 
†Note: 
Knowledge scores of 0-4 implies poor knowledge levels 
Knowledge scores of 5-8 implies good knowledge levels 
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4.7 Determining predictors and associations between knowledge levels, demographic 
and clinical factors at post-intervention for the experimental group   
 
4.7.1 Factors associated with knowledge improvement on fluid and salt control post-
intervention. 
 
Table 4.12 displays the results of the univariate and multivariate analysis for factors 
affecting knowledge improvement post-intervention for the experimental group. 
Explanatory variables or factors with significance levels of 0.2 and below (p≤ 0.20) in the 
univariate analyses were included in the multivariate logistic regression analysis. 
 
As shown in Table 4.12, in the univariate analysis, the proportion of participants with 
knowledge improvement was lower in patients who had experienced fluid overload 
(38.2%). The proportion of participants with knowledge improvement was higher in those 
who had received advice on fluid and salt control (40 %) than those who reported not 
receiving such advice (33.3%). 
 
Proportion of knowledge improvement (38.8%) was reported  low among those who had 
not received verbal advice, however, the association was not found to be significant. 
Likewise, the majority (60.0%) of those who received written advice reported non-
improvement (p>0.05). 
 
The highest percentages of knowledge improvement were found for the following factors; 
participants above 60 years old (45.5%), female (57.6%), of minority ethnicity (66.7%), 
unmarried (45.2%), uneducated (62.5%) unemployed (60.8%), and less than 5 years of 
dialysis therapy (46.3%). Regardless of the frequency of concurrent disease, there was a 
higher proportion of patients with no improvement in knowledge than the proportion that 
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reported improvement. There were lower proportions in knowledge improvement among 
patients taking antihypertensive medication (40.0%) than those who were not on any 
antihypertensive medication (43.5%). With regards to the number of antihypertensive 
medications, the proportion of knowledge improvement was lower among those with a 
greater number of antihypertensive medications. 
 
As shown in Table 4.12, the variables included in multivariate analyses were advice 
received, frequency of advice received, and duration of dialysis therapy, marital status, 
number of concurrent diseases, and number of antihypertensive medication used.  The 
multivariate logistic model indicated that the number of hypertensive medication taken by 
patients was the only     significant predictor of knowledge improvement (OR 2.27, 95% 
CI 0.08 to 0.79) than the subgroup with more than one antihypertensive medication. In 
the test for goodness of fit, the chi-square value for the Hosmer-Lemeshow test was 7.43 
with a significance level of 0.49 (significance value more than 0.05) implying a good fit.  
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Table 4.12: Results of multivariate logistic regression analysis predicting post-
intervention knowledge improvement in the experimental group 
 
  
 
 
 
 
 
Knowledge 
 improvement  
 
 
 
n (%) 
Univariate 
 
X
2
 
p 
 
 
β Multivariate 
logistic regression 
model 
of  improved vs. 
non improved 
knowledge§ 
Factors N=154 
 
ǂImproved Non 
improved 
 
  OR (95%CI) 
 
 
 
 
 
 
 
Fluid overload 
experience 
 
 
 
      
  
Yes  102 39(38.2) 63(61.8) 0.24 - - 
No 52 25(48.1) 27(51.9)    
Advice received 
previously 
     
 
 
Yes  145 58(40) 87(60) 0.12 -0.78 0.46(0.06-3.68) 
No 9 3(33.3) 6(66.7)  - Reference 
Form of teaching 
received previously 
      
Verbal 121 47(38.8) 74(61.2)    
Written /leaflet 5 2(40) 2(60) 0.51 - - 
Verbal & written  18 9(50) 9(50)    
Personal  
background 
      
Age group        
  
  
 
 
  
 
<40yrs 42 18(42.9) 24(57.1)    
40-50yrs  25 9(36.0) 16(64.0)    
50-60yrs 43 17(39.5) 26(60.5) 0.87 - - 
>60yrs 
  
44 20(45.5) 24(54.5)  
 
 
 
 
 
  
Gender     
 
 
0.85 
  
Male  88 36(40.9) 52(59.1)   
Female  66 28(57.6) 38(42.4) 0.85 - - 
Ethnicity        
        Malay 93 36(38.7) 57(61.3)    
        Chinese 44 20(45.5) 24(54.5) 0.71 - - 
         Indian 
 
14 6(42.9) 8(57.1)    
        Others 3 
2(66.7) 
1(33.1)    
Marital status     
 
0.20 
 
 
 
 
Single 
 
 
 
 
42 19(45.2) 23(54.8) 
 
0.38 1.47(0.54-3.95) 
Married 94 414(3.6) 53(56.4) 0.20 1.22(0.51-2.93) 
Widow/widower 18 4(22.2) 14(77.8) - Reference 
Note:  
ǂKnowledge improvement: knowledge level changes from low (score 0-4) to high (score 5-8) 
§ Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 7.43, P = 0.49  
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‘Table 4.12, continued’ 
 
  
 
 
 
 
 
Knowledge 
 improvement  
 
 
 
n(%) 
Univariate 
 
X
2
 
p 
 
 
β Multivariate 
logistic regression 
model 
of  improved vs. 
non improved 
knowledge§ 
Factors N=154 
 
Improvedǂ Non 
improved 
 
  OR (95%CI) 
 
 
 
 
 
 
 
Educational level     
 
 
0.63 
 
 
 
- 
 
 
 
- 
No education 8 59(62.5) 3(37.5) 
Primary 26 11(42.3) 15(57.7) 
Secondary 80 33(41.2) 47(58.8) 
Tertiary 40 15(37.5) 25(62.5) 
Employment  status      
 
 
- 
 
 
 
- 
Retired 50 
 
 
 
23(46.0) 27(54.0)  
Unemployed 51 20(60.8) 31(39.2) 0.69 
Full time 45 19(57.8) 2642.2  
Part time 8 2(25.0). 6(75.0)  
 
 
Duration of dialysis 
therapy  
      
< 5yrs 54 25(46.3) 29(53.7)  0.42 1.52(0.59-3.94) 
5-10yrs 46 17(37.0) 29(63.0) 0.19 0.34 1.40(0.53-3.75) 
10-15yrs 39 1(41.0) 23(59.0)  0.52 1.68(0.61-4.62) 
>15yrs 15 6(40) 9(60.0)  - Reference 
No. of concurrent 
disease 
    
 
  
Nil 33 12(36.4) 21(63.6)  -0.54 0.58(0.21-1.57) 
< 2 types 76 37(48.7) 39(51.3) 0.20 0.56 1.75(0.89-3.40) 
>2 types  
 
 
45 15(33.3) 30(67.7)  - Reference 
 
 Antihypertensive 
therapy 
    
 
 
0.66 
 
 
 
- 
 
 
 
- 
Yes 85 34(40) 51(60) 
No 
 
69 30(43.5) 39(56.5) 
No. of  
antihypertensive 
medications   
 
 
 
0.19 
  
0  70 31(55.7) 39(44.3) 0.82 2.27(1.08-4.79)* 
1  36 18(50.0) 18(50.0) 
 
0.40 1.49(0.71-3.13) 
> 1  
 
48 15(31.2) 33(68.8) - Reference 
Note:  
ǂKnowledge improvement: knowledge level changes from low (score 0-4) to high (score 5-8) 
§ Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 7.43, P = 0.49  
*Significant level p<0.05 
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4.8 Determining fluid compliance pre- and post- intervention in the experimental 
and control group 
 
4.8.1 Comparison of fluid compliance at pre- and post-intervention for both the 
experimental and control groups  
 
Comparison of pre- and post-intervention fluid compliance for the experimental and 
control groups is depicted in Table 4.13. Within the experimental group comparison, the 
mean IDWG during the pre-intervention phase (2.34kg±0.73) was higher than at the 1-
month (1.98kg±0.54), 3-month (1.99kg±0.54) and 6-month (2.00kg±0.76) post-
intervention phase respectively. In the experimental group, comparison of the baseline 
mean IDWG with the 6-month post-intervention mean IDWG, showed a significant 
reduction of 0.35kg (95%CI 0.25 to 0.45). In the control group, there was no significant 
difference for the mean IDWG between the baseline and 6-month post-intervention (OR 
0.002, 95%CI 0.09 to 0.08). Comparison between the experimental and control groups 
revealed significant differences for all mean IDWG reductions at 1-month (p = 0.02), 3-
month (p = 0.00) and 6-month (p = 0.00) post-intervention respectively. 
 
There were no significant differences in MPBP means in the experimental and control 
groups (104.75mmHg±12.06 vs. 104.73mmHg±13.06) during the pre-intervention phase. 
In both the experimental and control group, there were no significant differences in the 
reduction of mean MPBP from baseline to 6-month post intervention (p > 0.05).  There 
were significant changes in mean MPBP between the control and experimental groups in 
the post-intervention phase. The mean MPBP (±SD) in the experimental groups were 
105.67mmHg±12.43 to 104.70mmHg±12.26 and 105.41mmHg±13.18 to 
106.38mmHg±11.34 at the post-intervention phase (Table 4.13). There were no 
significant differences between the experimental and control groups in all mean MPBP 
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reductions between the two groups for the 1-month, 3-month and 6-month post-
intervention, respectively.  
 
The mean RFA baseline for both the experimental and control groups were 
47.14%±25.92 and 49.04%±24.93, respectively. The within group comparison revealed a 
significant increase in mean RFA in the experimental group 6-month post- intervention 
(17.77, 95% CI 13.84 to 21.70), however, the increase in mean RFA in the control group 
was not statistically significant (1.29, 95% CI 2.71 to 5.29). There were significant 
differences (p = 0.00) in the mean RFA of the experimental group versus the control 
group at 1-month (68.54%±23.23 vs. 50.75%±29.34), 3-month (64.58%±25.33 vs. 
46.88%±26.65), and 6-month (64.66%±24.86 vs. 48.91%±25.91) post-intervention. 
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Table 4.13: Comparison of fluid compliance between experimental and control groups at 1-month, 3-month and 6-month and  
within each group from baseline to 6-month. 
 
Variables Group 
 
Baseline Between groups  
(Experimental vs. control) 
Within each groups 
(6 –month 
vs. baseline) 1-month 3-month 6-month 
 Mean  
(SD) 
Mean 
(SD) 
Diff 
(95%) 
p Mean 
(SD) 
Diff 
(95%) 
p Mean 
(SD) 
Diff 
(95%) 
p Diff 
(95%) 
p 
IDWG/ 
kg 
Experiment
al  
2.34 
(0.73) 
1.98 
(0.54) 
 
-0.21 
(-0.34, 
-0.08) 
 
 
 
0.02 
1.99 
(0.54) 
 
-0.25 
(-0.40, 
-0.11) 
 
 
 
<.001 
2.00 
(0.76) 
 
-0.21 
(-0.35, 
-0.07) 
 
 
 
<.001 
0.35 
(0.25, 
0.45) 
<.001 
 
Control  2.22 
(0.55) 
2.20 
(0.55) 
2.24 
(0.65) 
2.22 
(0.76) 
-.002 
(-0.09, 
0.08) 
0.96 
MPBP 
/mmHg 
Experiment
al  
104.7
5 
(12.06
) 
105.67 
(12.43) 
 
 
0.26 
(-2.86, 
3.38) 
 
 
 
0.87 
105.34 
(12.28) 
 
 
-1.04 
(-3.95, 
1.86) 
 
 
 
0.48 
104.70 
(12.26) 
 
 
-0.45 
(-3.5, 
2.60) 
 
 
 
0.77 
0.09 
(-1.48, 
1.65) 
0.91 
 
Control  104.7
3 
(13.06
) 
105.41 
(13.18) 
106.38 
(11.34) 
105.15 
(12.72) 
-0.46 
(-2.38, 
1.47) 
0.64 
RFA/% Experiment
al  
47.14 
(25.92
) 
68.54 
(23.23) 
 
 
17.79 
(11.39, 
24.18) 
 
 
 
 
<.001 
64.56 
(25.33) 
 
 
17.68 
(11.33
, 
24.03) 
 
 
 
<.001 
64.66 
(24.86) 
 
 
15.75 
(9.55, 
21.96) 
 
 
 
<.001 
-17.77 
(-21.7, 
13.84) 
<.00
1 
 
Control  49.04 
(24.93) 
50.75 
(29.34) 
46.88 
(26.65) 
48.91 
(25.91)  
1.29 
(-
2.71,5.29) 
0.52 
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4.8.2 Trends of fluid compliance at pre- and post-intervention for both the control and 
experimental group 
 
Fluid compliance (IDGW, MPBP and RFA) was measured at both the pre-intervention 
(baseline) and post-intervention phase (1-month, 3-month and 6-month). The trends for fluid 
compliance at baseline, 1-month, 3-month and 6-month are displayed in Figure 1, 2 and 3. 
 
The line graph (Figure 4.1) shows the linear trend of the IDWG at baseline, 1-, 3-, and 6-
month. There was a significant decrease in the IDWG at 1- month post-intervention (p <0.05) 
and a minor increase at 3- and 6 -month post intervention for the experimental group (p< 
0.001). The IDWG for the control group remained stable at baseline and post-intervention.  
 
A mixed between-within subject ANOVA (combination of between-subjects ANOVA and 
repeated measures ANOVA) was conducted to assess whether there were IDWG differences 
in experimental and control groups across four time periods (pre-intervention, one-month, 
three-month and six-month). 
 
The following assumptions were tested; a) independence of observations and normality were 
met b) assumption of sphericity was violated. The Greenhouse-Geisser Epsilon was used to 
correct the degrees of freedom.  
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The result of the analysis showed that there was a significant difference in change of IDWG 
over the baseline, 1-, 3- and 6-month intervention for the experimental and control groups 
(Wilks’ lambda = 0.89, F (3,258) = 10.77, p<0.001, Partial Eta Squared = 0.11). The effect 
size, Partial Eta Squared (0.11) indicated a very large effect size (Cohen, 1988). The main 
effect comparing the experimental and control groups was significant, F (1,260) = 4.31, p 
<0.05, Partial Eta Squared = 0.02, which suggested significant differences in IDWG between 
the experimental and control groups. The effect size, Partial Eta Squared (0.02) indicated a 
very small effect size (Cohen, 1988). 
  
**Significant level at p<0.05 (p<.001) 
 
Figure 4.1: Line graph showing linear trend of IDWG/kg at baseline 1-, 3-, and 6-month 
 
 
 
 
 
Baseline 1-month 3-month 6-month
Experimental 2.24 1.98 1.99 2.00
Control 2.22 2.20 2.24 2.20
1.85
1.9
1.95
2
2.05
2.1
2.15
2.2
2.25
2.3
IDWG / kg  
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Figure 4.2 shows the linear trend of the MPBP /mmHg at baseline 1-, 3-, and 6-month . 
Generally, the MPBP reading in the experimental group was lower than in the control group.  
The trend showed an increase in the MPBP from baseline to 1-month post-intervention in the 
experimental group (104.75mmHg to 105.67mmHg) and a decrease to 104.70mmHg at 6-
month post- intervention. In the control group, there was an increase in the MPBP at baseline 
and at 3-month post-intervention (104.73mmHg to 106.38mmHg) which decreased to 105.15 
mmHg at 6-month post-intervention. This was found to be not significant (p = 0.77). 
 
 
A mixed between-within subject ANOVA was conducted to assess whether there were 
MPBP differences in experimental and control groups across the four time periods (pre-
intervention, one-month, three-month and six-month). There was no statistically significant 
difference in MPBP change from the baseline over the 1-, 3-, and 6-month intervention for 
both the experimental and control groups, Wilks’ lambda = 0.99, F (3,258) = 0.64, p>0.05 , 
Partial Eta Squared = 0.007. The main effect of comparing the two groups was not 
significant, F (1,260) = 0.04, p = 0.84, Partial Eta Squared = 0.00, suggesting there was no 
difference in MPBP between the experimental and control groups. 
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*Not 
significant p>0.05 (p=0.77) 
 
Figure 4.2: Line graph showing linear trend of MPBP/mmHg at baseline 1-, 3-, 
and 6-month 
 
Figure 4.3 showed the trend of the RFA for both the experimental and control groups, pre- 
and post-intervention. There was a huge increase in RFA at baseline compared to 1-month 
post intervention (47.14% to 68.54%, p<0.001) which remained stagnant at 3- and 6- month 
(64.56% and 64.66% respectively) post-intervention for the experimental group. There were 
minor changes (p<0.001) in the RFA in the control group at baseline (49.04%) and at 1-
month (50.75%), which decreased to 46.88 % (3-month) and increased significantly 
(p<0.001) again to 48.91% at 6-month post-intervention. 
 
 
 
 
Baseline 1-month 3-month 6-month
Experimental 104.75 105.67 105.34 104.70
Control 104.73 105.41 106.38 105.15
103.5
104
104.5
105
105.5
106
106.5
107
MPBP/mmHg 
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The results of the mixed between-within subject ANOVA revealed that there was significant 
difference in change of RFA over the baseline, 1-, 3-, and 6-month intervention for 
experimental and control groups, Wilks’ lambda = 0.82, F (3,258) = 19.26, p <0.001, Partial 
Eta Squared = 0.18. The effect size, Partial Eta Squared (0.18) indicated a very large effect 
size (Cohen, 1988). The main effect comparing the experimental and control groups was 
significant, F (1,260) = 18.98, p <0.001, Partial Eta Squared = 0.07, suggesting significant 
difference in RFA between the experimental and control groups. The Partial Eta Squared 
(0.007) indicated a very small effect size (Cohen, 1988). 
 
 
 
**Significant level at p<0.05 (p<.001) 
Figure 4.3: Line graph showing linear trend of RFA/% at baseline 1-, 3-, and 6-month 
 
 
 
 
 
 
Baseline 1-month 3-month 6-month
Experimental 47.14 68.54 64.56 64.66
Control 49.04 50.75 46.88 48.91
0
10
20
30
40
50
60
70
80
RFA/% 
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4.8.3 Fluid compliance levels pre- and post-intervention for both the experimental and 
control groups. 
 
 
a) Interdialytic weight gain (IDWG) 
Compliance refers to participants with IDWGs of 2 kg and below, while participants with 
IDWGs of more than 2 kg were considered non-compliant. The proportion of compliance on 
the IDWG was 31.0% and 35.0% respectively at pre-intervention for both the experimental 
and control groups. There was no significant difference in the proportion of compliance with 
IDWG between the experimental and control group (p=0.49).  However, the proportion of 
compliance on the IDWG in the experimental group was found to be increased in the post-
intervention phase. In the experimental group, there was a statistically significant increase in 
the proportion of patients who complied with the IDWG at 1-month (58.6 %), 3-month 
(65.5%) and 6-month (62.8 %) post-intervention (Table 4.14). 
 
The compliance level for the control group remained low or almost unchanged at post-
intervention with 35.0% at one-month, and 33.3% at three-month and six-month follow-up 
respectively. There were significant differences in the proportion of compliance on the 
IDWG between the experimental and control groups post-intervention for all phases (Table 
4.14). McNemar’s test was conducted to compare the baseline IDWG compliance with 
IDWG compliance within group at six-month post-intervention. The results revealed a 
significant difference (p= 0.00) in compliance levels for all experimental groups post-
intervention.   
 
 
  
Table 4.14: Compliance with interdialytic weight gain (IDGW) pre- and post-intervention 
 
 
 
 
 
Pre- intervention  
(Between groups) 
 
 Post- intervention 
 (Between groups)  
 Within group 
(6 –month 
vs. baseline) 
IDWG Baseline Exp. 
vs. 
control 
2 
 1-month Exp. 
vs. 
control 
2 
 
3- month Exp. 
vs. 
control 
2 
6-month Exp. 
vs. 
control 
2 
 Mc 
Nemar 
Test 
 C† 
n 
(%) 
 
NCǂ 
n 
(%) 
p  C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n  
(%) 
 
p   
Patients’ 
Group 
 
 
 
              
Experimental 
(N=145) 
45  
(31.0
) 
100 
(69.0) 
 
 
 
0.49 
 
 
 
 85 
(58.6) 
60 
(41.4) 
 
 
 
 
<.001 
95  
(65.5) 
50 
(34.5) 
 
 
 
<.001 
91 
(62.8) 
54 
(37.2) 
<.001  
 
 
 
<.001 
Control 
(N=117) 
41  
(35.0) 
76 
(65.0) 
 41 
(35.0) 
76 
(65.0) 
 39 
(33.3) 
78 
(66.7) 
 39 
(33.3) 
78 
(66.7) 
  0.82 
Note: 
C† Compliance:       IDWG ≤ 2kg  
NCǂ Noncompliance: IDWG >2kg 
115 
 
  
b) Mean pre-dialysis blood pressure (MPBP) 
 
Table 4.15 shows compliance levels measured using the MPBP pre- and post-intervention 
in both the experimental and control groups. Compliance was defined as a MPBP of 100 
mmHg and below while non-compliance was defined as a MPBP above100mmHg. There 
were no significant differences between the proportion of patients who complied with the 
MPBP at baseline and post-intervention. In the pre-intervention phase, the proportion of 
compliance was 34.5% and increased to 35.9 %( one- month), 35.2% (three-month) and 
39.3 % ( six-month) for the experimental group. Comparison between experimental and 
control groups revealed no statistical significant differences (p>0.05) in both groups pre- 
and post-intervention phases. The results of the comparison within group for both 
experimental and control groups showed no significant differences at six-month post-
intervention with p=0.30 and 1.00 respectively.  
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Table 4.15:Compliance with mean predialysis blood pressure (MPBP) pre- and post-intervention 
 
 
 
 
 
Pre- intervention  
(Between groups) 
 
 Post- intervention 
 (Between groups)  
 Within group 
(6 –month 
vs. baseline) 
MPBP Baseline Exp. 
vs. 
control 
2 
 1-month Exp. 
vs. 
control 
2 
 
3- month Exp. 
vs. 
control 
2 
6-month Exp. 
vs. 
control 
2 
 Mc 
Nemar 
Test 
 C† 
n 
(%) 
 
NCǂ 
n 
(%) 
p  C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n  
(%) 
 
p   
Patients’ 
Group 
 
 
 
              
Experimental 
(N=145) 
50 
(34.5) 
95 
(65.5) 
 
 
 
 
0.57 
 
 
 
 52 
(35.9) 
 
93 
(64.1) 
 
 
 
 
0.34 
51 
(35.2) 
94 
(64.8) 
 
 
 
 
0.07 
57 
(39.3) 
 
88 
(60.7) 
 
 
 
 
0.32 
 
 
 
 
0.30 
 
 
Control 
(N=117) 
39 
(33.3) 
 
78 
(66.7) 
 
 36 
(30.8) 
 
81 
(69.2) 
 
 29 
(24.8) 
 
88 
(75.2) 
 
 38 
(32.5) 
 
79 
(67.5) 
  1.00 
Note: 
C† Compliance: MPBP ≤ 100mmHg 
NCǂ Noncompliance: MPBP>100mmHg 
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c) Rate of fluid adherence (RFA) 
 
RFA compliance was defined an adherence rate of more than 75% to recommended 
interdialytic weight gain between dialysis intervals. Compliance levels measured using 
the RFA pre- and post-intervention in both the experimental and control groups are 
displayed in Table 4.16. There were no significant difference in RFA compliance for both 
experimental and control groups in the pre-intervention phase (17.2% and 21.4%, 
respectively, p=0.40). At post-intervention, the experimental group showed tremendous 
increase in compliance levels from 17.2% to 62.1% at one-month, which was sustained at 
three- and six-month (50.3%). The results showed significant differences in RFA 
compliance between the experimental and control groups at one-month, three-month and 
six-month post-intervention. The comparison between pre-and six month post-
intervention within group showed significant differences in the experimental group 
(p=0.00) 
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Table 4.16: Compliance with rate of fluid adherence (RFA) at pre and post- intervention 
 
 
 
 
 
Pre- intervention  
(Between groups) 
 
 Post- intervention 
 (Between groups)  
 Within 
group 
(6 –month 
vs. baseline) 
RFA Baseline Exp. 
vs. 
contro
l 
2 
 1-month Exp. 
vs. 
contro
l 
2 
 
3- month Exp. 
vs. 
control 
2 
6-month Exp. 
vs. 
control 
2 
 Mc 
Nemar 
Test 
 C† 
n 
(%) 
 
NCǂ 
n 
(%) 
p  C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n 
(%) 
 
p C† 
n 
(%) 
 
NCǂ 
n  
(%) 
 
p   
Patients’ 
Group 
 
 
 
              
Experimental 
(N=145) 
25 
(17.2) 
 
120 
(82.8) 
 
 
 
0.40 
 90 
(62.1) 
 
55 
(37.9) 
 
 
 
<.00
1 
73 
(50.3) 
 
72 
(49.7) 
 
 
 
<.001 
73 
(50.3) 
 
72 
(49.7) 
 
 
 
 
<.001 
 <.001 
 
Control 
(N=117) 
25 
(21.4) 
 
92 
(78.6) 
 
 28 
(23.9) 
 
89 
(76.1) 
 24 
(20.5) 
 
93 
(79.5) 
 
 
 24 
(20.5) 
 
93 
(79.5) 
 
  1.00 
Note: 
C† Compliance: RFA ≥ 75%  
NCǂ Noncompliance: RFA < 75% 
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4.90 Evaluating the effectiveness of patient education on fluid compliance 
improvement at 1-, 3- and 6-month post-intervention for both the 
experimental and control groups. 
 
4.9.1 Fluid compliance outcome at 1-month post-intervention for both the 
experimental and control groups 
The three indicators for fluid compliance were categorised into two groups- compliance 
and noncompliance. The compliance group included interdialytic weight gain (IDWG) of 
less than 2kg, mean pre-dialysis blood pressure (MPBP) of less than 100mmHg, and an 
adherence rate of more than 75%. Improvement in compliance refers to change from 
patient non-compliance at pre-intervention to compliance at any of the post-intervention 
phases. 
Table 4.17 showed the outcome for fluid compliance improvement one-month post- 
intervention for the IDWG, MPBP and RFA.    
The experimental group 
There were 85 participants who demonstrated compliance on the IDWG post-
intervention. Of these 65 participants improved from noncompliance to compliance while 
20 participants maintained compliance pre- and post-intervention. 
There were 52 participants who demonstrated compliance on the MPBP post-
intervention. Twenty-one of these participants improved noncompliance to compliance 
whereas 31 participants maintained compliance pre- and post-intervention.  
There were 90 participants who were compliant on the RFA post-intervention, from 
which 69 participants showed an improved from noncompliance to compliance while 21 
participants maintained compliance pre- and post-intervention.  
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The control group  
There were 41 participants who demonstrated compliance on the IDWG post-
intervention, which consisted of 12 participants who showed improvement from 
noncompliance to compliance and 29 participants who maintained compliance pre- and 
post-intervention. 
Of thirty six participants who demonstrated compliance on the MPBP post-intervention, 
14 participants improved from noncompliance to compliance while 22 participants 
maintained compliance pre- and post-intervention.  
There were 28 participants who demonstrated compliance on the RFA post-intervention, 
from which 12 participants improved from noncompliance to compliance while 16 
participants maintained compliance pre- and post-intervention. 
Both experimental and control groups showed improved compliance on the IDWG, 
MPBP and RFA at 1-month post-intervention (Table 4.17). The proportion of participants 
that showed compliance improvement on the IDWG was higher in the experimental group 
(35.9%) than the control group (10.3%). The odds ratio (OR 4.89, 95%CI 2.40 to 9.72) 
showed that the experimental group had nearly 5 times higher odds of compliance 
improvement than the control group at one-month post-intervention.  
Improvement in baseline MPBP compliance was slightly higher in the experimental 
group (14.5%) than the control group (12.0%). The participants in the experimental group 
did not show much improvement in MPBP compliance compared to the control group, as 
reflected by the small odds ratio value (OR 1.25, 95%CI 0.60 to 2.57). The experimental 
group only had one time higher odds of compliance improvement than the control group  
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at one-month post-intervention. The odds ratio was not statistically significant at α = 0.05. 
The proportion of participants with compliance improvement on the RFA was the highest 
among the three indicators; the experimental group had a higher percentage (47.6%) than 
the control group (10.3%). The odds ratio (OR 7.94, 95%CI 4.02 -15.68) showed the 
experimental group had almost eight times higher odds of compliance improvement than 
the control group at 1-month post-intervention. 
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Table 4.17: Outcome for fluid compliance 1-month post-intervention 
 
 Experimental  
(N=145) 
 Experiment
al group 
compliance 
improved in 
1 month 
post  
intervention 
 Control 
(N=117) 
 Control 
group 
compliance 
improved in 
1 month post 
intervention 
 Odds ratio 
(95%CI) of 
improved 
compliance 
for 
experimental 
vs. control     
 Baseline 1month  n (%)  Baseline 1 month  n (%)   
IDWG†    52 
(35.9) 
   12 
(10.3) 
4.89 
(2.40 -9.72) 
≤2kg 45 
(31) 
85 
(58.6) 
 41 
(35) 
 
41 
(35.0) 
 
> 2kg 100 
(69) 
60 
(41.4) 
 76 
(65) 
76 
(65.0) 
 
 
MPBP†    21 
(14.5) 
   14 
(12.0) 
1.25 
(0.60-2.57) 
≤100mmH
g 
50 
(34.5) 
 
52 
(35.9) 
 39 
(33.3) 
36 
(30.8) 
 
> 
100mmHg  
95 
(65.5) 
93 
(64.1) 
 78 
(66.7) 
81 
(69.2) 
 
 
RFA †    69 
(47.6) 
   12 
(10.3) 
7.94 
(4.02-15.68) 
≥75% 25 
(17.2) 
90 
(62.1) 
 
 25 
(21.4) 
28 
(23.9) 
 
< 75% 120 
(82.8) 
55 
(37.9) 
 92 
(78.6) 
 
89 
(76.1) 
 
†Note: Compliance 
Interdialytic weight gain (IDWG): ≤ 2kg  
Mean predialysis blood pressure (MPBP): ≤100mmHg  
Rate of fluid adherence (RFA): ≥75%  
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4.9.2 Outcome for fluid compliance at 3-month post-intervention for both 
experimental and control groups  
 
Table 4.18 showed outcome for fluid compliance improvement three-month post-
intervention for the IDWG, MPBP and RFA. 
The experimental group 
There were 95 participants who demonstrated compliance on the IDWG post-
intervention. Of these 57 participants improved from noncompliance to compliance while 
38 participants maintained compliance pre- and post-intervention. 
Fifty one participants showed compliance on the MPBP post-intervention. Of these, 16 
participants improved from noncompliance to compliance and 35 participants maintained 
compliance pre- and post-intervention.  
Seventy-three participants demonstrated compliance on the RFA post-intervention, from 
which 53 participants improved from noncompliance to compliance while 20 participants 
maintained compliance pre- and post-intervention.  
The control group  
There were 39 participants who demonstrated compliance on the IDWG post-
intervention. Of these, 7 participants showed improvement from noncompliance to 
compliance while 32 participants maintained compliance pre- and post-intervention. 
There were 29 participants who demonstrated compliance on the MPBP post-
intervention, which consisted of 11 participants who improved from noncompliance to 
compliance while 18 participants maintained compliance pre- and post-intervention.  
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Twenty-four participants demonstrated compliance on the RFA post-intervention. Of 
these 11 participants improved from noncompliance to compliance while 13 participants 
maintained compliance pre- and post-intervention. 
Table 4.18 displays results for both the experimental and control groups, which showed 
improved compliance on the IDWG, MPBP and RFA at three-month post-intervention. 
The percentage of compliance improvement was lower at three-month compared to one-
month post-intervention. However, the proportion of participants that showed compliance 
improvement on the IDWG was still higher in the experimental group (39.6%) than the 
control group (6.0%). The odds ratio (OR 10.30, 95%CI 4.47 to 23.70) showed the 
experimental group had 10 times higher odds of compliance improvement than the 
control group post-intervention. 
The compliance improvement on the MPBP remained low at three-month post 
intervention, but the percentage for the experimental group was still higher (11.0%) than 
the control group (9.4%).  
The odds ratio for the experimental group had one higher odds of compliance 
improvement than the control group post-intervention (OR 1.20, 95%CI 0.53 to 2.69). 
The odds ratio was not statistically significant at α = 0.05. The proportion of participants 
that showed compliance improvement on the RFA compared to the baseline was higher in 
the experimental group (36.6%) than the control group (9.4%). The odds ratio (OR 5.55, 
95%CI 2.74 to 11.26) showed the experimental group had an almost six times higher odds 
of compliance improvement than the control group at three-month post-intervention. 
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Table 4.18: Outcome for fluid compliance 3- month post –intervention 
 
 
 Experimental (n=145)  Experimen
tal group 
complianc
e improved 
in 3-month 
post 
interventio
n 
 Control (n=117)  Control 
group 
complianc
e improved 
in 3-month 
post 
interventio
n 
 Odds ratio 
(95% CI) of 
improved 
compliance for 
experimental vs. 
control 
 Baseline 3 month n (%) Baseline 3 month n(%)  
IDWG†   57(39.6)   7(6.0) 10.30 
(4.47-23.70) ≤2kg 45 
(31) 
 
95 
(65.5) 
41 
(35) 
 
39 
(33.3) 
>2 kg  100 
(69) 
50 
(34.7) 
76 
(65) 
78 
(66.7) 
        
MPBP†   16(11.0) 
 
  11(9.4) 1.20 
(0.53-2.69) ≤100mmHg 50 
(34.5) 
 
51 
(35.2) 
39 
(33.3) 
29 
(24.8) 
>100mmHg 95 
(65.5) 
94 
(64.8) 
78 
(66.7) 
88 
(75.2) 
        
RFA†   53(36.6)   11(9.4) 
 
5.55 
(2.74-11.26) 
≥75% 25 
(17.2) 
73 
(50.3) 
25 
(21.4) 
24 
(20.5) 
< 75% 120 
(82.8) 
72 
(49.7) 
92 
(78.6) 
93 
(79.7) 
†Note: Compliance 
Interdialytic weight gain (IDWG): ≤ 2kg  
Mean predialysis blood pressure (MPBP): ≤100mmHg  
Rate of fluid adherence (RFA): ≥75%  
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4.9.3 Outcome for fluid compliance at 6-month post-intervention for both the  
         experimental and control groups. 
 
Table 4.19 showed outcome for fluid compliance improvement 6-month post- 
intervention 
The experimental group 
Ninety-one participants demonstrated compliance on the IDWG post-intervention. Of 
these, 39 participants improved from noncompliance to compliance while 52 participants 
maintained compliance pre- and post-intervention. 
There were 57 participants who demonstrated compliance on the MPBP post-
intervention, from which 19 participants improved from noncompliance to compliance 
while 38 participants maintained compliance pre- and post-intervention.  
Of 73 participants who demonstrated compliance on the RFA post-intervention, 53 
participants improved from noncompliance to compliance and 20 participants maintained 
compliance pre- and post-intervention.  
The control group  
There were 39 participants who demonstrated compliance on the IDWG post-
intervention. From these, 8 participants improved from noncompliance to compliance and 
31 participants maintained compliance pre- and post-intervention. 
Of 38 participants who showed compliance on the MPBP post-intervention, 16 
participants improved from noncompliance to compliance while 22 participants 
maintained compliance pre-and post-intervention.  
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There were 24 participants who demonstrated compliance on the RFA post-intervention. 
Of these, 11 participants improved from noncompliance to compliance while 13 
participants maintained compliance pre- and post-intervention.  
There was an increase in compliance percentage  for the three fluid compliance indicators 
at six- month post intervention compared to the baseline, which was up 62.8% (IDWG) 
from the baseline at 31%, 39.3% (MPBP) from the baseline 34.5% and 50.3% (RFA) 
from the baseline of 17.2% (Table 4.19). The proportion of participants that showed 
compliance improvement on the IDWG was higher in the experimental group (33.8%) 
than the control group (6.8%). The odds ratio (OR 6.95, 95%CI 3.14 to15.42) showed that 
the experimental group had a nearly 7 times higher odds of compliance improvement than 
the control group at six-month post-intervention.  
There was no difference in the percentage of compliance improvement on the MPBP; 
both groups had similar percentages (13.1% and 13.7% respectively). Participants from 
the experimental group did not show compliance improvement but the experimental 
group had a nearly 1 time higher odds of compliance improvement than the control  group 
at 6-month post-intervention as reflected by the odds ratio (OR 0.95, 95%CI 0.47 to 
1.95). The odds ratio was not statistically significant at α = 0.05. 
The percentage of compliance improvement on the RFA remained unchanged at 3-month 
and 6-month. The proportion of participants in the experimental group had a higher 
percentage (36.6%) than the control group (9.4%). The odds ratio of RFA improvement at 
6-month post-intervention (OR 5.55, 95%CI 2.74 to11.26) was similar to the odds ratio at 
3-month post-intervention.  
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Table 4.19: Outcome for fluid compliance 6-month post intervention 
 Experimental 
(N=145) 
 Experiment
al group 
compliance 
improved 
in 6-month 
post-
intervention 
 Control (N=117)  Control  
group 
compliance 
improved 
in 6-month 
post-
intervention 
 Odds ratio 
(95%CI) of 
improved 
compliance for 
experimental vs. 
control 
 Baseline 6 
month 
n (%) Baseline 6 
month 
n (%)  
IDWG † 
 
  49(33.8)   8(6.8%) 
 
6.95 
(3.14-15.42) 
 ≤2kg 45 
(31) 
91 
(62.8) 
41 
(35) 
 
39 
(33.3) 
> 2kg  100 
(69) 
 
54 
(37.2) 
76 
(65) 
78 
(66.7) 
        
MPBP † 
 
  19(13.1)   16(13.7%) 0.95 
(0.47-1.95) 
≤100mmHg 
 
50 
(34.5) 
57 
(39.3
%) 
39 
(33.3) 
38 
(32.5) 
 
>100 
mmHg 
95 
(65.5) 
88 
(60.7
%) 
78 
(66.6) 
79 
(67.5) 
        
RFA †  
 
  53(36.6)   11(9.4%) 5.55 
(2.74-11.26) 
≥75% 25 
(17.2%) 
 
73 
(50.3) 
25 
(21.4) 
24 
(20.5) 
<75% 120 
(82.8) 
72 
(49.7) 
92 
(78.6) 
93 
(79.5) 
 
†Note: Compliance  
Interdialytic weight gain (IDWG): ≤ 2kg  
Mean predialysis blood pressure (MPBP): ≤100mmHg   
Rate of fluid adherence (RFA): ≥75% 
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4.10 Determining the predictors and association between fluid compliance, 
demographic factors and knowledge post-intervention in the experimental 
group. 
 
4.10.1 Factors associated with fluid compliance improvement at 1-, 3-, and 6-month 
post   intervention for the experimental group  
 
The factors associated with fluid compliance on three indicators – IDWG, MPBP and 
RFA were analysed using univariate and multivariate analysis. Table 4.20 to 4.28 
displays the results of the Chi-square test (univariate) and logistic regression 
(multivariate) analysis of factors affecting compliance improvement post-intervention for 
noncompliant participants in the experimental group (n = 100).  
 
4.10.1.1 Factors associated with interdialytic weight gain (IDWG) compliance 
improvement at 1-, 3- and 6-month post-intervention in the experimental 
group 
 
a) Factors associated with IDWG compliance improvement and predictors of 
compliance improvement on the IDWG: comparing the baseline to 1-month post-
intervention 
 
One hundred participants were identified as noncompliant on the IDWG at the pre-
intervention phase. The univariate analysis of proportion for compliance improvement on 
the IDWG at baseline and 1-month post-intervention is shown in Table 4.20. Participants 
above 60 years of age (60.0%), females (54.3%), of Indians ethnicity (58.3%) married 
(52.5%), without formal education (100.0%) with more than 15 years of dialysis therapy 
(71.43%), and part time employment (80.0%), with no concurrent disease (69.6%), and 
no antihypertensive therapy (58.3%) showed the highest IDWG improvement.  
Participants who had poor knowledge of fluid and salt control showed higher proportions 
(52.5%) of IDWG improvement than those who had good knowledge. 
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As shown in Table 4.20, only one variable (number of concurrent diseases) with p≤0.2 
was included in the multivariate logistic regression analysis. Participants with no 
concurrent disease were more likely to have IDWG improvement (OR 2.00, 95%CI 0.95 
to 4.21) than the group with more than two concurrent diseases. However, the logistic 
model indicated that the number of concurrent disease was not a significant predictor of 
IDWG improvement (p>0.05). In the test for goodness of fit, the Chi-square value for the 
Hosmer-Lemeshow test was 0.00 with a significance level of 1.00 (p >0.05), implying a 
good fit. 
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Table 4.20: Results of the logistic regression analysis predicting IDWG compliance 
improvement at 1-month post-intervention for the experimental group 
 
Factors  
 
 
Respondents n(%) 
 
Univariate 
χ
2 
p
 
 
β 
Logistic regression model of  
improved vs. non improved 
compliance
§
 Improvedǂ Non 
improved 
Personal 
background 
N=100      
Age group     
 
 
 
0.33 
 
 
 
 
- 
 
 
 
 
- 
<40yrs 29 16(55.2) 13(44.8) 
40-50yrs 18 6(33.3) 12(66.7) 
50-60yrs 30 18(60.0) 12(40.0) 
>60yrs 23 12(52.2) 11(47.8) 
Gender     
 
0.74 
 
 
- 
 
 
- Male 65 33(50.8) 32(49.2) 
Female 35 19(54.3) 16(45.7) 
Ethnicity       
Malay 61 33(54.1) 28(45.9)    
Chinese 25 12(48) 13(52) 0.45 - - 
Indian 12 7(58.3) 5(41.7)    
Others 2 0 2(100)    
Marital status     
 
 
0.99 
 
 
 
- 
 
 
 
- 
Single 
 
 
 
27 14(51.9) 13(48.1) 
Married 59 31(52.5) 28(47.5) 
Widow/widower 14 7(50) 7(50) 
Educational level     
 
 
0.78 
 
 
 
 
- 
 
 
 
- 
Primary and 
below 
18 10(55.6) 8(44.4) 
Secondary 54 29(53.7) 25(46.3) 
Tertiary 28 13(46.4) 15(53.6) 
 
Employment  status     
 
 
0.39 
 
 
 
- 
 
 
 
- 
Retired 31 17(54.8) 14(45.2) 
Unemployed 31 17(54.8) 14(45.2) 
Full time 33 14(42.4) 19(57.6) 
Part time 5 4(80) 1(20) 
Note: 
ǂImproved: Noncompliance becomes compliance 
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (1) = 0.00, p = 1.00 
# Knowledge 0-4 (poor knowledge) 
Knowledge 5-8( good  knowledge) 
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‘Table 4.20, continued’ 
 
 
Factors  
 
 
Respondents n(%) 
 
Univariate 
χ
2 
p
 
 
β 
Logistic regression model of  
improved vs. non improved 
compliance
§
 Improvedǂ Non 
improved 
Personal 
background 
N=100      
Duration of dialysis 
therapy 
     
 
 
 
- 
 
 
 
 
- 
< 5yrs 37 15(40.5) 22(59.5)  
5-10yrs 28 14(50) 14(50) 0.39 
10-15yrs 28 18(64.3) 10(35.7)  
>15yrs 7 5(71.4) 2(28.6) 
 
 
No.  of concurrent 
disease 
    
 
 
 
 
 
 
 
Nil 23 16(69.6) 7(30.4)  
 
0.69 
 
2.00(0.95-4.21) 
< 2 48 22(45.8) 26(54.2) 0.15 0.25 
 
1.29(0.67-2.48) 
 
>2 29 14(48.3) 15(51.7)  - Reference 
Antihypertensive 
therapy 
     
 
 
- 
 
 
 
- 
Yes 52 24(46.2) 
 
28(53.8)  
0.22 
No 48 28(58.3) 20(41.7)  
No.of anti-
hypertensive 
medication 
 
 
 
 
  
0 48 28(58.3) 20(41.7) 
0.47 
 
 
- 
 
 
 
- 1 21 10(47.6) 11(52.4) 
>1 31 13(41.9) 18(58.1) 
Knowledge#     
 
 
0.93 
 
 
 
- 
 
 
 
- 
0- 4 40 21(52.5) 19(47.5) 
5-8 60 31(51.7) 29(48.3) 
Note: 
ǂImproved: Noncompliance becomes compliance 
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (1) = 0.00, p = 1.00 
# Knowledge 0-4 (poor  knowledge) 
Knowledge 5-8(good  knowledge) 
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b) Factors associated with the IDWG compliance improvement and predictors of 
compliance improvement on the IDWG: comparing the baseline to 3-month post- 
intervention for the experimental group. 
 
The results of the univariate analysis in Table 4.21 show the proportion of IDWG 
compliance improvement from baseline to three-month post-intervention as grouped by 
variable. Participants from the 50-60 age bracket (65.5%) who were female (62.9%), 
Malay (62.3%) widowed (61.6%), with primary education and below (61.10%), 
unemployed (65.6%), with a duration of 10-15 years of dialysis therapy (71.4%), and no 
concurrent disease (73.9%), as well as no antihypertensive therapy (58.3%) showed 
higher IDWG compliance improvement. However, participants on a single type of 
antihypertensive medication had a higher percentage (71.4%) than any other subgroup. 
Participants with “poor knowledge level” on fluid and salt control showed higher 
proportions (67.5%) of improved IDWG compliance than those with good knowledge 
level (50%) 
. 
 
As shown in Table 4.21, the variables included in the multivariate analysis were duration 
of dialysis therapy, number of concurrent diseases, the number of antihypertensive 
medication and knowledge on fluid and salt control.  The multivariate logistic model 
showed that none of the variables were significant predictors of IDWG improvement 
(p>0.05), as all the CIs included a 1 between the value. In the goodness of fit test, the 
Chi-square value for the Hosmer-Lemeshow Test was 6.81 with a significance level of 
0.45 (p > 0.05), implying a good fit. 
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Table 4.21: Results of multivariate logistic regression analysis predicting IDWG 
compliance improvement at 3-month post-intervention for the experimental group 
 
Factors  
 
 
 
Respondents n(%) Univariate 
χ
2 
p 
β Multivariate  logistic 
regression model 
of  improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
Personal 
 background 
N=100      
Age group      
 
 
0.33 
 
 
 
- 
 
 
 
- 
<40yrs 29 17(56.7) 13(43.3) 
40-50yrs  18 7(38.9) 11(61.1) 
50-60yrs 30 19(65.5) 10(34.5) 
>60yrs  23 14(60.9) 9(39.1) 
Gender     
 
0.39 
 
 
- 
 
 
- 
Male  65 35(53.8) 30(46.2) 
Female  35 22(62.9) 13(37.1) 
Ethnicity       
Malay 61 38(62.3) 24(37.7)  
0.63 
 
- 
 
- Chinese 25 13(52) 11(48) 
Indian  12 5(41.7) 7(58.3) 
Others  2 1(50) 1(50) 
Educational  level     
 
 
0.81 
 
 
 
 
- 
 
 
 
- 
Primary and below  18 11(61.1) 7(38.9) 
Secondary 54 31(57.4) 23(42.6) 
Tertiary 28 15(53.6) 13(46.4) 
Employment  status     
 
 
0.53 
 
 
 
- 
 
 
 
- 
Retired 31 18(58.1) 13(41.9) 
Unemployed 32 21(65.6) 11(34.4) 
Full time 32 16(50) 16(50) 
Part time 5 2(40.0) 3(60.0) 
Duration of dialysis  
therapy  
      
< 5yrs 37 21(55.3) 17(44.7)  
 
0.17 1.18(0.42-3.32) 
5-10yrs 28 12(42.9) 16(57.1) 0.12 -0.40 0.67(0.22-2.080) 
10-15yrs 28 20(71.4) 8(28.6)  0.75 2.12(0.73-6.19) 
>15yrs 7 5(71.4) 2(28.6)  - Reference 
No. of concurrent 
disease 
    
 
 
 
0.12 
 
 
 
 
- 
 
 
Nil 23 17(73.9) 6(26.1) 0.12 1.13(0.42-3.06) 
< 2 48 23(47.9) 25(52.1) -0.340 0.712(0.34-1.48) 
>2 
 
32 17(58.6) 12(41.4) - Reference 
Note: 
ǂImproved: Noncompliance to compliance  
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§
 Logistic regression model; Hosmer and Lemeshow test, 2 (7) = 6.81, P = 0.45 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
‘Table 4.21, continued’ 
 
Factors  
 
 
 
Respondents n(%) Univariate 
χ
2 
p 
β Multivariate  logistic 
regression model 
of  improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
 
Personal 
 background 
N=100      
Antihypertensive 
therapy 
    
 
 
0.80 
 
 
 
- 
 
 
 
- 
Yes 52 29(55.8) 23(44.2) 
No 48 28(58.3) 20(41.7) 
No antihypertensive 
medication 
   
 
 
0 48 28(58.3) 20(41.7) 
0.17 
 
0.32 
- 
1.03(0.44-2.40) 
 1 21 15(71.4) 6(28.6) 0.03 
 
1.37(0.614-3.07) 
 >1 31 14(45.2) 17(54.8) - Reference 
Knowledge#      
0-4 40 27(67.5) 13(32.5) 0.08 0.24 1.27(0.70-2.27) 
5-8 60 30(50) 30(50) - Reference 
Note: 
ǂImproved: Noncompliance to compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (7) = 6.81, P = 0.45 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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c) Factors associated with IDWG compliance improvement and predictors of 
compliance improvement on the IDWG: comparing the baseline to 6-month post-
intervention for the experimental group. 
 
The univariate analysis of proportion by the highest percentage for various factors was 
conducted for IDWG compliance improvement from baseline to 1 -month (Table 4.22). 
Participants from the 50-60 age bracket (53.3%), who were female (54.3%), single 
(55.6%), uneducated (100.0%), retired (58.1%), more than 10-15 years of dialysis therapy 
(60.7%), no concurrent disease (65.2%), and no antihypertensive therapy (56.2%) showed 
the highest IDWG compliance improvement. Participants who had poor knowledge of 
fluid and salt control showed higher proportions (52.5%) of IDWG compliance 
improvement than those with good knowledge. 
 
The variables included in multivariate analysis were the duration of dialysis therapy, 
number of concurrent diseases, antihypertensive therapy, number of antihypertensive 
medication and knowledge on fluid and salt control. However, all the factors did not 
significantly predict IDWG compliance improvement as indicated by all the CIs, which 
included one. In the test for goodness of fit, the chi-square value for the Hosmer-
Lemeshow Test was 8.56 with a significance level of 0.38 (p > 0.05) implying a good fit. 
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Table 4.22: Results of multivariate logistic regression analysis predicting IDWG 
compliance improvement at 6-month post-intervention for the experimental group. 
 
 
Factors  Respondents n(%)   
 
Univariate 
χ
2 
p 
β Multivariate logistic 
regression model 
of  improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
 
Personal  
background 
N=100    
Age group      
 
 
 
0.75 
 
 
 
 
- 
 
 
 
 
 
- 
<40yrs 29 13(44.8) 16(55.2) 
40-50yrs  18 7(38.9) 11(61.1) 
50-60yrs 30 16(53.3) 14(46.7) 
>60yrs  23 12(52.2) 11(47.8) 
Gender     
 
0.36 
 
 
 
 
- 
 
 
- Male  65 29(44.6) 36(55.4) 
Female  35 19(54.3) 16(45.7) 
Ethnicity       
Malay 
 
61 
 
3(049.1) 
 
31(50.8) 
 
 
 
0.97 
 
 
- 
 
 
- 
Chinese 25 12(48.0) 13(52.0) 
Indian  12 5(29.2) 7(58.3) 
Others  2 1(50) 15(0) 
Educational level     
 
 
0.30 
 
 
 
- 
 
 
 
- 
Primary and below 18 9(50.0) 9(50.0) 
Secondary 54 29(53.7) 25(46.3) 
Tertiary 28 10(35.7) 
 
18(64.3) 
Employment status     
 
 
0.59 
 
 
 
- 
 
 
 
- 
Retired 31 18(58.1) 13(41.9) 
Unemployed 31 14(54.8) 17(45.2) 
Full time 33 14(42.4) 19(57.6) 
Part time 5 2(40.0) 3(60.0) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 8.56, P = 0.38 
# Knowledge 0-4 (poor knowledge) 
Knowledge 5-8(good knowledge) 
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‘Table 4.22, continued’ 
 
 
 
 
 
 
Factors 
 Respondents n(%) 
 
Univariate 
χ
2 
p 
β Multivariate 
logistic regression 
model 
of  improved vs. 
non improved 
compliance
§
   Improvedǂ Non 
improved 
 
  
Personal  
background 
N=100      
Duration of dialysis 
therapy  
 
 
 
    
< 5yrs 
 
37 13(35.1) 24(64.9)  
 
0.12 
-0.48 
 
-0.19 
 
0.63 
 
- 
0.62(0.20-1.84) 
 
0.82(0.27-2.52) 
 
1.87(0.63-5.54) 
 
Reference 
5-10yrs 28 
 
13(46.4) 15(53.6) 
10-15yrs 28 
 
17(60.7) 11(39.3) 
>15yrs 7 5(71.4) 2(28.6) 
No. of concurrent 
disease 
    
 
 
 
0.13 
 
 
 
-0.52 
 
-0.76 
- 
 
 
 
0.60(0.215-1.65) 
 
0.47(0.214-1.03) 
Reference 
Nil 23 15(65.2) 8(34.8) 
< 2 types 48 19(39.6) 29(60.4) 
>2 types  29 14(48.3) 15(51.7) 
 
 
 
Antihypertensive 
therapy  
    
 
 
0.11 
 
 
 
-0.57 
- 
 
 
 
0.57(0.27-1.22) 
Reference 
Yes  52 21(40.4) 31(59.6) 
No  
 
48 27(56.2) 21(43.8) 
No. antihypertensive 
medication   
 
 
 
 
 
  
  
  
- 
0  48 27(56.2) 
 
21(43.8) 
0.27 
1  21 8(38.1) 
 
13(61.9) 
> 1  
 
41 13(41.9) 18(58.1) 
Knowledge#      
 
0.48 
- 
 
 
1.62(0.85-2.99) 
Reference 
0-4 40 23(57.5) 17(42.5) 0.12 
5-8 60 25(41.7) 35(58.3) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 8.56, P = 0.38 
# Knowledge 0-4 (poor knowledge) 
Knowledge 5-8(good knowledge)                             139 
  
4.10.1.2 Factors associated with MPBP compliance improvement at 1-, 3-, and 6-
month post- intervention in the experimental group. 
 
a) Factors associated with the MPBP compliance improvement and predictors of 
compliance improvement on the MPBP: comparing the baseline to 1-month post- 
intervention for the experimental group. 
 
There were 95 noncompliant participants on the MPBP in the pre-intervention phase. The 
univariate analysis for MPBP compliance improvement which compared the baseline to 
the 1-month post-intervention showed on overall a higher proportion of non-improvement 
compared to the proportion with improvement. From the Table 4.23, it was indicated that 
the highest proportion of MPBP compliance improvement were participants in the 60 and 
above age bracket (34.6%), male (47.6%), Chinese (40%), widowed (30.8%) with 
primary education (37.5.0%), retired (27.6%), with a duration of dialysis therapy of 10-15 
years (39.1%), with more than 2 concurrent illnesses (36.7%), on antihypertensive 
therapy (22.6%), and participants who were on more than 1 type of antihypertensive 
medication (28.9%). Participants who had poor knowledge of fluid and salt control 
showed a higher proportion of MPBP compliance improvement (25.0%) than those who 
had good knowledge. 
 
The factors included in the multivariate analysis were age group, duration of dialysis 
therapy, and number of concurrent diseases. The multivariate logistic model indicated the 
number of concurrent disease as the only significant predictor of MPBP compliance 
improvement (OR 0.08 95%CI 0.10 to 0.71). In the test for goodness of fit, the Chi-
square value for the Hosmer-Lemeshow test was 2.49 with a significance level of 0.96 
(p > 0.05), implying a good fit. 
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Table 4.23: Results of the multivariate logistic regression analysis predicting MPBP 
compliance improvement at 1-month post-intervention for the experimental group. 
 
Factors  
 
 
 
Respondents n(%) 
 
Univariat
e 
χ
2 
p 
β Multivariate logistic 
regression model 
of  improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
 
Personal 
 background 
N=95 
 
    
Age group      
 
 
 
0.18 
  
<40yrs 19 2(10.5) 17(89.5) -1.13 0.32(0.06-1.62) 
 
40-50yrs  22 3(13.6) 19(86.4) -0.20 
 
0.82(0.28-2.40) 
 
50-60yrs 28 7(25.0) 21(75.0) 0.02 
 
1.02(0.42-2.45) 
 
>60yrs  
 
 
 
 
26 9(34.6) 17(65.4) - Reference 
Gender     
 
 
0.39 
  
 
 
- 
 
 
 
- 
Male  53 10(47.6) 43(58.1) 
Female  42 11(26.2) 31(73.8) 
Ethnicity       
Malay 58 9(15.5) 49(84.5)  
 
0.63 
 
 
- 
 
 
- 
Chinese 25 10(40) 15(60) 
Indian  10 2(20) 8(80) 
Others  2 0 2(100) 
Educational  level     
 
 
0.22 
 
 
 
- 
 
 
 
- 
Primary and below 20 7(35.0) 13(65.0) 
Secondary 51 11(21.6) 40(78.4) 
Tertiary 24 3(12.5) 21(87.5) 
Employment  status     
 
 
0.68 
 
 
 
- 
 
 
 
- 
Retired 29 8(27.6) 21(72.4) 
Unemployed 29 7(24.1) 22(75.9) 
Full time 33 5(15.2) 28(84.8) 
Part time 
 
4 1(25.0) 3(75.0) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 2.49, P = 0.96 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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‘Table 4.23, continued’ 
 
Factors  Respondents n(%) 
 
Univariat
e 
χ
2 
p 
      β                     Multivariate logistic 
regression model 
of  improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
 
Personal  
Background  
N=95     
Duration of therapy       
< 5yrs 32 5(15.6) 27(84.4) 0.07 0.97 
 
1.39 
 
1.87 
 
- 
2.631(0.30-23.02) 
 
4.012(0.46-34.82) 
 
6.46(0.74-56.51) 
 
Reference 
5-10yrs 32 7(21.9) 25(78.1) 
10-15yrs 23 9(39.1) 14(60.9) 
>15yrs 8 0 8(100) 
No. of concurrent 
disease 
    
 
0.05 
 
 
-2.47 
 
-0.55 
 
- 
 
 
0.08(0.10-0.71)* 
 
0.57(0.250-1.33) 
 
Reference 
Nil    11 1(9.1) 10(90.9) 
< 2   54 9(16.7) 45(83.3) 
>2   
 
30 11(36.7) 19(63.3) 
Antihypertensive 
therapy  
   0.88  - 
Yes  62 14(22.6) 48(77.4) 
No  33 7(21.2) 26(78.8) 
No antihypertensive 
medication   
   
 
  
0  33 7(21.2) 26(78.8) 
0.31 
 
 
  
  
- 
1 24 3(12.5) 21(87.5) 
>1 38 11(28.9) 27(71.1) 
Knowledge#       
0-4 32 8(25.0) 24(75.0) 0.62  - 
5-8  63 13(20.6) 50(79.4) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (8) = 2.49, P = 0.96 
*Significance level at p<0.05 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good  knowledge) 
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b) Factors associated with the MPBP compliance improvement and predictors of 
compliance improvement on the MPBP: comparing the baseline to 3-month post- 
intervention for the experimental group. 
 
The univariate analysis of proportion on MPBP  compliance improvement comparing the 
baseline to 3-month post intervention showed the highest proportion of improvement in 
the 60 and above age bracket (23.1%) as well as in females (26.2%),widows (38.5%), 
those with no  education or primary education  (both 25%), retirees (27.6%), and those 
with a duration of dialysis therapy of 5-10 years (21.9%) as well as participants who had 
more than 2 concurrent illnesses (20.0%) and whom were not on any antihypertensive 
therapy (18.2%) (Table 4.24). Participants who had good knowledge of fluid and salt 
control showed higher proportions (20.6%) of MPBP compliance improvement than those 
who had poor knowledge. 
 
Explanatory variables with significance level of 0.2 and below (p≤ 0.2) in univariate 
analyses were included in the multivariate logistic regression model. The variables 
included in the multivariate analysis were gender, marital status, and knowledge of fluid 
and salt control. The multivariate logistic model indicated that marital status was the only 
significant predictor of MPBP improvement (p<0.05). Married participants had a lower 
odds of MPBP compliance improvement (OR 0.29, 95% CI 0.11to 0.77) than those who 
were widowed, collectively. Single participants had a lower odds of MPBP compliance 
improvement (OR 0.19, 95%CI 0.05 to 0.71) than the widowed group. In the test for 
goodness of fit, the Chi-square value for the Hosmer-Lemeshow test was 2.90 with a 
significance level of 0.82 (p > 0.05), implying a good fit. 
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Table 4.24: Results of the multivariate logistic regression analysis predicting MPBP 
compliance improvement at 3-month post-intervention for the experimental group. 
 
 
Factors  
 
 
 
Respondents n (%)   Univariate 
X
2
 
p 
β Multivariate 
logistic 
regression 
model 
of  improved 
vs.non improved 
compliance
§
 
Improvedǂ Non 
improved 
 
Personal 
 background 
N=95      
Age group      
 
 
0.45 
 
 
 
- 
 
 
 
- 
<40yrs 19 2(10.5) 17(89.5) 
40-50yrs  22 2(9.1) 20(90.9) 
50-60yrs 28 6(21.4) 22(78.6) 
>60yrs  26 6(23.1) 20(76.9) 
Gender     
 
0.03 
 
 
 
 
 
 
Male  53 5(9.4) 48(90.6) 
 
-0.64 
 
0.53(0.23-1.21) 
 
Female  42 11(26.2) 3173.8 - Reference 
Ethnicity       
Malay 58 5(8.6) 53(91.4)    
Chinese 25 8(32.0) 17(68) 0.22 - - 
Indian  10 3(30) 7(100)    
Others  2 0 -    
Marital status     
 
 
0.07 
  
Single 
 
 
 
18 4 (21.0) 15(79.0) -1.66 0.19(0.05-0.71)* 
Married 64 8(12.5) 56(87.5) -1.25 0.29(0.11-0.77)* 
Widow/widower 13 5(38.5) 8(61.5) - Reference 
Educational level     
 
 
0.33 
 
 
 
- 
 
 
 
- 
Primary and below 20 5(25.0)  15(75.0) 
Secondary 51 9(17.6) 42(82.40 
Tertiary 24 2(8.3) 22(91.7) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 2.90, P = 0.82 
*Significance level at p<0.05  
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good  knowledge) 
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‘Table 4.24, continued” 
 
 
Factors   Respondents 
 n(%) 
Univariate 
X
2
 
p 
β Multivariate 
logistic 
regression model 
of  improved 
vs.non improved 
compliance
§
 
Improvedǂ  Non 
improved 
 
Personal 
 background 
N=95      
Employment status     
 
 
 
0.25 
 
 
 
 
- 
 
 
 
 
- 
Retired 29 8(27.6) 21(72.4) 
Unemployed 29 4(13.8) 25(86.2) 
Full time 33 3(9.1) 30(90.9) 
Part time 4 1(25.0) 3(75.0) 
Duration of dialysis 
therapy  
      
< 5yrs 32 3(9.4) 29(90.6)  
 
0.50 
 
 
- 
 
 
- 
5-10yrs 32 7(21.9) 25(78.1) 
10-15yrs 23 5(21.7) 18(78.3) 
>15yrs 8 1(12.5) 7(87.5) 
No. of concurrent disease     
 
 
0.71 
 
 
 
- 
 
 
 
- 
Nil 11 1(9.1) 10(90.9) 
< 2   
 
54 9(16.7) 45(83.3) 
>2 
 
30 6(20) 24(80) 
Antihypertensive therapy      
 
 
0.80 
 
 
 
- 
 
 
 
- 
Yes  62 10(16.1) 52(83.9) 
No  33 6(18.2) 27(81.8) 
No antihypertensive 
drugs   
   
 
 
 
 
 
-- 
 
 
 
 
 
0  33 6(18.2) 27(81.8) 
0.81 
 
 
- 
 
 
- 
1 24 3(12.5) 21(87.5) 
>1 38 7(18.4) 31(81.6) 
Knowledge#       
0-4 32 3(9.4) 29(90.6) 0.16 -0.80 
- 
0.45(0.19-1.13) 
Reference 
5-8 63 13(20.6) 50(79.4) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 2.90, P = 0.82 
*Significance level at p<0.05  
# Knowledge 0-4 (poor  knowledge) 
   Knowledge 5-8(good  knowledge)                              145 
  
c) Factors associated with the MPBP compliance improvement and predictors of 
compliance improvement on the MPBP: comparing the baseline to 6-month post- 
intervention for the experimental group. 
 
The univariate analysis of proportion on MPBP compliance improvement comparing the 
baseline to 6-month post-intervention showed that the highest proportions of compliance 
improvement were in participants aged 60 years and above (30.8%) as well as in those 
who were female (21.4%), widowed (38.5%), retired (31.0%), with only primary 
education (31.2%), a duration of dialysis therapy of 5-10 years (37.5%), with more than 2 
concurrent disease(26.7%), and not on any antihypertensive therapy (24.2%) (Table 
4.25). Participants who had good knowledge of fluid and salt control had higher 
proportions (22.2%) of MPBP compliance improvement than those with poor knowledge. 
 
The variables included in the multivariate analysis (p ≥ 0.2) were marital status and 
duration of dialysis therapy. However, both variables were found to be non-significant 
predictor of MPBP compliance improvement as indicated by the CIs that included one. In 
the test for goodness of fit, the Chi-square value for the Hosmer-Lemeshow Test was2.82 
with a significance level of 0.83 (p > 0.05), implying a good fit. 
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Table 4.25: Results of multivariate logistic regression analysis predicting compliance 
improvement of MPBP in the 6-month post-intervention for the experimental group 
 
 
Factors  
 
 
 
Respondents n(%) Univariate 
χ
2 
p 
β Multivariate logistic 
regression model 
of  improved vs. non 
improved 
compliance
§
 
Improvedǂ Non 
improved 
 
Personal 
 background 
N=95      
Age group      
 
 
 
0.31 
 
 
 
 
- 
 
 
 
 
- 
<40yrs 19 2(10.5) 17(89.5) 
40-50yrs  22 3(13.6) 19(86.4) 
50-60yrs 28 6(21.4) 22(78.6) 
>60yrs  26 8(30.8) 18(69.2) 
Gender     
 
0.76 
 
 
 
 
 
 
- 
 
 
- Male  53 10(18.9) 4(381.1) 
Female  
 
 
 
 
 
 
 
 
 
 
42 9(21.4) 33(78.6) 
Ethnicity       
Malay 60 12(20.7) 48(79.3)    
- 
-- 
Chinese 25 5(20) 20(80) 0.92 - - 
Indian  10 2(20) 8(80)    
Others  2 0 2(100)    
Marital status     
 
 
0.08 
 
  
 
 Single 
 
 
 
18 1(5.6) 17(94.4) -3.06 
 
0.05(0.01-0.40) 
 
Married 64 13(20.3) 51(79.7) -0.55 0.578(0.23-1.46) 
Widow/widower 13 5(38.5) 8(61.5) - Reference 
Educational level     
 
 
0.40 
 
 
 
- 
 
 
 
- 
Primary and primary 20 6(30.0) 14 (70.0) 
Secondary 51 8(15.7) 43(84.3) 
Tertiary 24 5(20.8) 19(79.2) 
Employment status     
 
 
 
0.33 
 
 
 
 
- 
 
 
 
 
- 
Retired 29 9(31.0) 20(69.0) 
Unemployed 29 4(13.8) 25(86.2) 
Full time 33 5(15.2) 28(84.8) 
Part time 4 1(25.0) 3(75.0) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 2.82, P = 0.83 
# Knowledge 0-4 (poor knowledge) 
  Knowledge 5-8(good knowledge)               147 
  
 
‘Table 4.25, continued’ 
 
 
Factors   Respondents n(%) 
 
Univariate 
χ
2 
p 
β Multivariate logistic 
regression model 
of  improved vs. non 
improved 
compliance 
  Improvedǂ Non 
improved 
 
Personal  
Background  
N=95      
Duration of dialysis 
therapy  
      
< 5yrs 32 3(9.4) 29(90.6)  
0.02 
1.35 
 
3.85(0.47-31.28) 
 
5-10yrs 32 12(37.5) 20(62.5) 1.88 
 
6.52(0.808-52.67) 
 
10-15yrs 23 4(17.4) 19(82.6) 1.24 
 
3.46(0.38-31.90) 
 
>15yrs 8 0 89(100.0) - Reference 
No. of concurrent 
disease 
    
 
 
 
 
0.54 
 
 
 
 
 
- 
 
 
 
 
 
- 
Nil 11 2(18.2) 9(81.8) 
 
< 2   
 
54 
 
9(16.7) 
 
45(83.3) 
 
>2   
 
30 
 
8(26.7) 
 
22(73.3) 
Antihypertensive 
therapy  
    
 
 
0.45 
 
 
 
- 
 
 
 
- Yes  62 11(17.7) 51(82.3) 
No  33 8(24.2) 25(75.8) 
No antihypertensive 
drugs   
   
0.54 
 
 
 
 
- 
 
 
 
 
- 
 
0  33 8(24.2) 25(75.8) 
1 24 3(12.5) 21(87.5) 
>1 38 8(21.1) 30(78.9) 
Knowledge#      
 
 
0.45 
 
 
 
- 
 
 
 
- 
0-4 32 5(15.6) 27(84.4) 
 
5-8 
 
63 
 
14(22.2) 
 
49(77.8) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 2.82, P = 0.83 
# Knowledge 0-4 (poor knowledge) 
  Knowledge 5-8(good knowledge)                148 
  
4.10.1.3 Factors associated with compliance improvement on the RFA at 1-, 3-, and 
6-month post-intervention for the experimental group. 
 
a) Factors associated with RFA compliance improvement and predictors of 
compliance improvement on the RFA: comparing the baseline to 1-month post- 
intervention for the experimental group. 
 
The univariate analysis of proportion with RFA compliance improvement comparing the 
baseline to 1-month showed the highest proportions of improvement among the 50-60 age 
bracket (66.7%), females (57.4%), those married (58.6%), with secondary  education 
(59.0%), employed part-time (83.3%), as well as those with a dialysis therapy duration of 
more than 15 years(77.8%), with no concurrent disease (69.2%), no antihypertensive 
therapy (57.1%), and those taking only on a single type of antihypertensive medication 
(Table 4.26). Participants who had poor knowledge of fluid and salt control showed 
higher proportions (62.0%) of RFA compliance improvement than those who had good 
knowledge. 
 
The single variable included in multivariate analysis was the duration of dialysis therapy. 
However, multivariate logistic regression analyses showed that dialysis therapy duration 
was not a significant predictor of RFA compliance as indicated by the CI that included 
one. In the test for goodness of fit, the Chi-square value for the Hosmer-Lemeshow test 
was 0.00 with a significance level of 1 (p > 0.05), implying a good fit. 
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Table 4.26: Results of the multivariate logistic regression analysis predicting the RFA 
compliance improvement at 1-month post intervention in the experimental group 
 
 
Factors   
 
 
 
Respondents n(%)   Univariate 
χ2 
p 
β Logistic regression 
model 
of  improved vs. 
non improved 
compliance
§
 
Improve
dǂ 
Non 
improved 
 
Personal 
background 
 N=120      
Age group      
 
 
 
0.40 
 
 
 
 
- 
 
 
 
 
- 
<40yrs 33 17(51.5) 16(48.5) 
40-50yrs  22 10(45.5) 12(54.5) 
50-60yrs 33 22(66.7) 11(33.3) 
>60yrs  32 19(59.4) 13(40.6) 
Gender     
 
0.89 
 
 
- 
 
 
- 
Male  73 41(56.2) 32(43.8) 
Female  47 27(57.4) 20(42.6) 
Ethnicity       
 
 
- 
Malay 63 42(57.5) 31(49.2)  
 0.96 
 
- 
Chinese 32 
 
 
 
17(53.1) 15(46.9) 
Indian  12 7(58.3) 5(41.7) 
Others  3 2(66.7) 1(5) 
Marital status     
 
 
0.82 
 
 
 
- 
 
 
 
- 
Single 
 
 
 
34 19(55.9) 15(44.1) 
Married 70 41(58.6) 29(41.4) 
Widow/widower 16 8(50.0) 8(50.0) 
Educational level     
 
 
0.65 
 
 
 
- 
 
 
 
- 
Primary and below 25 15(60) 10(40) 
Secondary 61 36(59.0) 25(41.0) 
Tertiary 34 17(50) 17(50) 
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (2) = 0.00, P = 1.00 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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‘Table 4.26, continued’ 
       
Factors   Respondents  n (%)  
  
 
 
Univariate 
χ2 
p 
β Logistic 
regression model 
of  improved vs. 
non improved 
compliance
§
 
Improve
d 
Non 
improved 
 
Personal 
 background 
 N=120      
Employment status     
 
 
0.36 
 
 
 
- 
 
 
 
- 
Retired 37 23(62.2) 14(37.8) 
Unemployed 37 18(48.6) 19(51.4) 
Full time 40 22(55.0) 18(45.0) 
Part time 6 5(83.3) 1(16.7) 
Duration of dialysis 
therapy  
     
< 5yrs 42 20(47.6) 22(52.4)  
0.17 
-0.69 
 
-0.95 
 
0.09 
 
- 
0.50(0.20-1.24) 
 
0.388(0.15-1.01) 
 
1.091(0.42-2.85) 
 
Reference 
5-10yrs 35 18(51.4) 17(48.6) 
10-15yrs 34 23(67.6) 11(32.4) 
>15yrs 9 7(77.8) 2(22.2) 
No. of concurrent 
disease 
    
 
 
 
0.25 
 
 
 
 
- 
 
 
 
 
 
- 
Nil  26 18(69.2) 8(30.8) 
< 2   57 28(49.1) 29(50.9) 
>2 37 15(59.5) 22(40.5) 
Antihypertensive 
therapy  
 
 
 
    
 
 
0.92 
 
 
 
- 
 
 
 
- 
Yes  64 36(56.2) 
 
2843.8 
No  
 
 
56 32(57.1) 24(42.9) 
No. antihypertensive 
medication  
 
 
 
0.73 
 
 
 
- 
 
 
 
- 
0 56 32(57.1) 24(42.9) 
1 
>1 
24 15(62.5) 9(37.5) 
1 40 21(52.5) 19(47.5) 
Knowledge#        
0-4 50 31(62.0) 19(38.0) 0.32 - - 
5-8 70 37(52.9) 33(47.1)    
Note: 
ǂImproved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (2) = 0.00, P = 1.00 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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b) Factors associated with RFA compliance improvement and predictors of 
compliance improvement on the RFA: comparing the baseline to 3-month post- 
intervention for the experimental group. 
 
Table 4.27 shows the univariate analysis of proportion with RFA improvement comparing 
the baseline to three-month post-intervention. The highest proportion of compliance 
improvement was observed in the 60 and above age group (56.2%), females (40.4%), 
minority ethnicity (66.7%), widows (50.0), those with primary education and below 
(48.0%), retirees (51.4%), duration of dialysis therapy of 10-15 years (61.8%), 
participants who had no concurrent disease (57.1%), those not on any antihypertensive 
therapy (44.6%), and those taking only a single type of antihypertensive medication 
(58.3%). Participants who had poor knowledge of fluid and salt control showed higher 
proportions (48.0%) of RFA compliance improvement than those who had good 
knowledge. 
The variables included in the multivariate analysis (p ≥ 0.2) were duration of dialysis 
therapy, number of concurrent diseases and number of antihypertensive medication. 
There were significant predictors of RFA compliance improvement as indicated by the 
CIs that did not include one. Participants with less than 5 years of dialysis therapy had 
lower odds (OR 0.15, 95%CI 0.03-0.78) than those above 15 years. Participants with less 
than two concurrent diseases had lower odds (OR 0.18, 95%CI 0.06-0.54) than those with 
more than two concurrent disease, and those taking one type of antihypertensive 
medication  having higher odds (OR 3.99, 95%CI 1.22-13.00) than more than one type of 
antihypertensive medications.  In the test for goodness of fit, the Chi-square value for the 
Hosmer-Lemeshow test was 2.26 with a significance level of 0.95 (p > 0.05), implying a 
good fit. 
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Table 4.27: Results of the multivariate logistic regression analysis predicting the RFA 
compliance improvement at3-month post-intervention for the experimental group. 
 
Variables  
 
 
 
 Respondents  n(%) Univariate 
χ
2 
p 
β 
Multivariate 
logistic regression 
model 
of  improved vs. 
non improved 
compliance
§
 
Improved† Non 
improved 
 
Personal 
 background 
N=120      
Age group        
<40yrs 33 13(39.4) 20(60.6)    
40-50yrs  22 7(31.8) 15(68.2)    
50-60yrs 33 15(45.5) 18(54.5) 0.31 - - 
>60yrs  32 18(56.2) 14(43.8)    
Gender       
Male  73 34(46.6) 39(53.4)  
0.50 
 
- 
 
- 
 
Female  
 
 
 
 
 
 
 
 
 
47 19(40.4) 28(59.6) 
Ethnicity         
Malay 73 36(49.3) 37(52.7)  
0.29 
 
- 
 
- 
  
Chinese 32 
 
 
 
12(37.5) 20(62.5)   
Indian  12 3(25) 9(75)   
Others  3 2(66.7) 1(33.3)   
Marital status     
 
 
 
0.87 
 
  
 
  
  
  
Single 
 
 
34 15(44.1) 19(55.9)    
Married 70 30(42.9) 40(57.1) 0.87 - - 
Widow/widower 16 8(50) 8(50)    
Educational level       
Primary and below 25 12(48.0) 13(52.0)    
Secondary 61 29(47.5) 32(52.5) 0.47 - - 
Tertiary 34 12(35.3) 22(64.7)    
Employment  status        
Retired 37 19(51.4) 18(48.6)    
Unemployed 37 17(45.9) 20(54.1) 0.52 - - 
Full time 40 14(35.0) 26(65.0)    
Part time 6 3(50) 3(50)    
Note: 
†Improved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (7) =2.26, P = 0. 95 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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‘Table 4.27, continued’ 
 
 
Factors    Respondents n(%) Univariate 
χ
2 
p 
β 
Multivariate 
logistic regression 
model 
of  improved vs. 
non improved 
compliance
§
 
  Improved† Non 
improved 
 
Personal  
background  
N=120      
Duration of dialysis  
therapy  
      
< 5yrs 42 14(33.3) 28(66.7)  -1.92 0.15(0.03-0.78)* 
5-10yrs 35 13(37.1) 22(62.9) 0.05 -1.56 0.21(0.04-1.13) 
10-15yrs 34 21(61.8) 13(38.2)  -0.18 0.83(0.17-4.14) 
>15yrs 9 5(55.6) 4(44.4)  - Reference 
No. of concurrent 
disease 
    
 
 
 
0.03 
   
Nil 26 15(57.1) 11(42.3) -0.19 0.82(0.20-3.44) 
< 2   57 18(31.6) 39(68.4) -1.71 0.18(0.06-0.54)** 
>2   37 20(54.1) 17(45.9) - Reference 
Antihypertensive 
therapy  
    
 
 
0.92 
 
 
 
- 
 
 
 
- 
Yes  64 28(43.8) 36 (56.2) 
No  56 25(44.6) 31(55.4) 
No. of antihypertensive 
medication   
   
 
  
0  56 25(44.6) 31(55.4) 0.19 0.35 1.42(0.44-4.56) 
1 24 14(58.3) 10(41.7) 
 
1.38 3.99(1.22-13.0)* 
>1 40 14(35.0) 26(65.0) - Reference 
Knowledge        
0-4 50 24(48.0) 26(52.0)  
0.48 
 
- 
 
- 
5-8 70 29(41.4) 41(58.6) 
Note: 
†Improved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (7) =2.26, P = 0. 95 
**Significance level at p<0.01 
*Significance level at p<0.05 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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c) Factors associated with RFA compliance improvement and predictors of 
compliance improvement on the RFA: comparing the baseline to 6-month post- 
intervention for the experimental group. 
 
The univariate analysis of proportion with RFA improvement comparing the baseline to 
6-month post-intervention showed the highest proportion of RFA compliance 
improvement in participants aged over 60 years (53.1%), males (45.2%), Malays (47.9%), 
those unmarried (55.9%), with no education (75.0%), part-time employment  (50.0%), 
and with a duration of dialysis therapy of more than 15 years (66.7%) as well as 
participants who had no concurrent diseases (65.%), and those not on any 
antihypertensive therapy (50.0%). Participants who had poor knowledge of fluid and salt 
control showed higher proportions (50.0%) of improved RFA (Table 4.28). 
 
The variables included in multivariate analysis were the duration of dialysis therapy and 
number of concurrent diseases. However, there were no significant predictors of RFA 
compliance improvement as all the CIs included one in the multivariate logistic model. In 
the test for goodness of fit, the Chi-square value for the Hosmer-Lemeshow Test was 6.96 
with a significance level of 0.54 (p > 0.05) implying a good fit. 
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Table 4.28: Results of the multivariate logistic regression analysis predicting the RFA 
compliance improvement at 6-month post-intervention in the experimental group. 
 
Factors  
 
 
 
Respondents n(%) Univariate 
χ2 
p 
β Multivariate logistic 
regression model of  
improved vs. non 
improved compliance
§
 
Improvedǂ Non 
improved 
Personal 
background 
N=120  
 
   
  
 
 
Age group      
 
 
0.59 
  
 
 
- 
<40yrs 33 15(45.5) 18(54.5)  
40-50yrs  22 8(36.4) 14(63.6) - 
50-60yrs 33 13(39.4) 20(60.6) 
>60yrs  32 17(53.1) 15(46.9) 
Gender     
 
0.78 
 
 
- 
 
 
- 
Male  73 33(45.2) 40(54.8) 
Female  47 20(42.6) 27(57.4) 
Ethnicity     
 
 
 
0.73 
 
 
 
 
- 
 
 
 
 
- 
  
Malay 73 35(47.9) 38(52.1)   
Chinese 32 
 
 
 
13(40.6) 19(59.4)   
Indian  12 4(33.3) 8(66.7)   
Others  3 1(33.3) 2(66.7)   
Marital status     
 
 
0.22 
 
 
 
- 
 
 
 
- 
 
Single 
 
 
 
34 19(55.9) 15(44.1) 
Married 70 29(41.4) 41(58.6) 
Widow/ 
widower 
16 5(31.2) 11(68.8) 
Educational level     
 
 
0.70 
 
 
 
- 
 
 
 
- 
Primary and 
below 
25 12(48.0)  13(52.0) 
Secondary 61 28(45.9) 33(54.1) 
Tertiary 34 13(38.2) 12(61.8) 
Employment  
status 
    
 
 
 
0.88 
 
 
 
 
- 
 
 
 
 
- 
Retired 37 18(48.6) 19(51.4) 
Unemployed 37 16(43.2) 21(56.8) 
Full time 40 16(40.0) 24(60.0) 
Part time 6 3(50.0) 3(50.0) 
Note: 
*Improved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 6.96, P = 0.54 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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‘Table 4.28, continued’ 
 
Factors  
 
  
Respondents n(%) 
Univariate 
χ2 
p 
β 
Multivariate logistic 
regression model 
of  improved vs. non 
improved 
compliance
§
 
Improvedǂ Non 
improved 
 
Personal  
background  
N=120       
Duration of 
dialysis therapy  
      
< 5yrs 42 12(8.6) 30(71.4)  -0.82 0.45(0.16-1.22) 
5-10yrs 35 14(40.0) 21(60.0) 0.01 -0.77 0.46(0.16-1.33) 
10-15yrs 34 21(61.8) 13(38.2)  0.24 1.26(0.46-3.53) 
>15yrs 9 6(66.7) 3(33.3)  - Reference 
No of concurrent 
disease 
    
 
 
0.02 
  
Nil 26 17(65.4) 9(34.6) -0.12 0.89(0.37-2.13) 
< 2 types 57 19(33.3) 38(66.7) -0.73 0.48(0.23-1.02) 
>2 types  37 17(45.9) 20(54.1) - Reference 
Antihypertensive 
therapy 
    
 
 
0.25 
 
 
 
- 
 
 
 
- Yes  64 25(39.1) 39(60.9) 
No  56 28(50.0) 28(50.0) 
No 
antihypertensive 
medication  
   
 
 
0.38 
 
 
 
 
 
- 
 
 
 
 
 
- 
 
0  56 28(50.0) 28(50.0) 
< 2  24 8(33.3) 16(66.7) 
> 2  40 17(42.5) 23(57.5) 
Knowledge#       
 
- 
 
 
- 0-4 50 25(50.0) 25(50.0) 0.28 
5-8 70 28(40.0) 42(60.0)  
Note: 
*Improved: Noncompliance becomes compliance  
§
 Logistic regression model; Hosmer and Lemeshow test, 2 (6) = 6.96, P = 0.54 
# Knowledge 0-4 (poor knowledge) 
   Knowledge 5-8(good knowledge) 
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4.11 Summary 
 This chapter provided the results of the data collected from 291 respondents although 
only 262 participated in the education intervention contributing to a response rate of 90%. 
Patient characteristics were presented in frequency, percentages and mean. The majority 
of the participants were middle aged, Malay, male, with secondary education; they were 
also mostly married, unemployed and were on an average of 8 years of dialysis therapy. 
The most common concurrent disease was hypertension followed by diabetes mellitus. 
The majority was on antihypertensive therapy and took at least two types of 
antihypertensive medication.   
Two thirds (65.6%) of participants reported experiencing fluid overload. Patients also 
reported difficulty in breathing as the most common symptom.  Almost all the 
participants (91.8%) had received advice on fluid control prior to this study, with doctors 
and nurses most often being the source of information. However, the advice was 
frequently given verbally only when problems had occurred. 
The experimental group had higher mean total knowledge scores compared to the control 
group, and there was a significance difference in knowledge levels between these groups 
post-intervention. The knowledge improvement was three times higher in the 
experimental group as compared to the control group. Findings from this study show that 
educational intervention may be an effective means of knowledge improvement. The 
multivariate analysis indicated the number of antihypertensive medication as the only 
significant predictor of knowledge improvement, in that participants who were not taking 
antihypertensive medications were more likely to have knowledge improvement. 
158 
  
Three indicators for fluid compliance were – interdialytic weight gain (IDWG), mean 
predialysis blood pressure (MPBP) and rate of fluid adherence (RFA). The IDWG and 
RFA compliance level increased significantly at 1-, 3- and 6-month post intervention in 
the experimental group compared to control group. However, there was no difference in 
MPBP compliance levels between the experimental and control group post-intervention.  
The odds ratio indicated the effectiveness of the education intervention on the 
experimental group. The results revealed that the experimental group had a higher odds 
ratio as compared to the control group. Multivariate logistic regression was performed to 
identify predictors for IDWG, MPBP and RFA compliance improvement. The findings 
showed there were no predictors for IDWG compliance improvement. The number of 
concurrent disease and marital status were significant predictors for MPBP compliance 
improvement, while the duration of dialysis therapy, number of concurrent disease and 
number of antihypertensive medications were significant predictors for RFA compliance 
improvement. 
The effect of patient education on fluid compliance appears to be a positive one in 
haemodialysis settings. However, the researcher feels that there is a need for the issue of 
discrepancy of effect in MPBP compliance improvement to be further explored in future 
studies. 
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